{
    "id": "dbpedia_1810_3",
    "rank": 49,
    "data": {
        "url": "https://link.springer.com/article/10.1007/s10654-020-00640-5",
        "read_more_link": "",
        "language": "en",
        "title": "Objectives, design and main findings until 2020 from the Rotterdam Study",
        "top_image": "https://static-content.springer.com/image/art%3A10.1007%2Fs10654-020-00640-5/MediaObjects/10654_2020_640_Fig1_HTML.png",
        "meta_img": "https://static-content.springer.com/image/art%3A10.1007%2Fs10654-020-00640-5/MediaObjects/10654_2020_640_Fig1_HTML.png",
        "images": [
            "https://pubads.g.doubleclick.net/gampad/ad?iu=/270604982/springerlink/10654/article&sz=728x90&pos=top&articleid=s10654-020-00640-5",
            "https://link.springer.com/oscar-static/images/darwin/header/img/logo-springerlink-39ee2a28d8.svg",
            "https://media.springernature.com/w72/springer-static/cover-hires/journal/10654?as=webp",
            "https://media.springernature.com/w215h120/springer-static/image/art%3A10.1007%2Fs10654-015-0082-x/MediaObjects/10654_2015_82_Fig1_HTML.gif",
            "https://media.springernature.com/w215h120/springer-static/image/art%3A10.1007%2Fs10654-017-0321-4/MediaObjects/10654_2017_321_Fig1_HTML.gif",
            "https://media.springernature.com/w215h120/springer-static/image/art%3A10.1007%2Fs10654-023-01094-1/MediaObjects/10654_2023_1094_Fig1_HTML.png",
            "https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10654-020-00640-5/MediaObjects/10654_2020_640_Fig1_HTML.png",
            "https://link.springer.com/oscar-static/images/logo-springernature-white-19dd4ba190.svg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "M. Arfan",
            "M. Kamran",
            "Brenda C. T",
            "Caroline C. W",
            "de Knegt",
            "Robert J",
            "Annemarie I",
            "Tamar E. C",
            "Robin P",
            "van Rooij"
        ],
        "publish_date": "2020-05-04T00:00:00",
        "summary": "",
        "meta_description": "The Rotterdam Study is an ongoing prospective cohort study that started in 1990 in the city of Rotterdam, The Netherlands. The study aims to unravel etiolo",
        "meta_lang": "en",
        "meta_favicon": "/oscar-static/img/favicons/darwin/apple-touch-icon-92e819bf8a.png",
        "meta_site_name": "SpringerLink",
        "canonical_link": "https://link.springer.com/article/10.1007/s10654-020-00640-5",
        "text": "Oeppen J, Vaupel JW. Demography. Broken limits to life expectancy. Science. 2002;296(5570):1029–31.\n\nPeto R, Doll R. There is no such thing as aging. BMJ. 1997;315(7115):1030–2.\n\nHofman A, Grobbee DE, de Jong PT, van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol. 1991;7(4):403–22.\n\nHofman A, Breteler MM, van Duijn CM, Krestin GP, Pols HA, Stricker BH, et al. The Rotterdam Study: objectives and design update. Eur J Epidemiol. 2007;22(11):819–29.\n\nHofman A, van Duijn CM, Franco OH, Ikram MA, Janssen HL, Klaver CC, et al. The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol. 2011;26(8):657–86.\n\nBiele G, Gustavson K, Czajkowski NO, Nilsen RM, Reichborn-Kjennerud T, Magnus PM, et al. Bias from self selection and loss to follow-up in prospective cohort studies. Eur J Epidemiol. 2019;34(10):927–38.\n\nBusija L, Lim K, Szoeke C, Sanders KM, McCabe MP. Do replicable profiles of multimorbidity exist? Systematic review and synthesis. Eur J Epidemiol. 2019;34(11):1025–53.\n\nHuitfeldt A, Swanson SA, Stensrud MJ, Suzuki E. Effect heterogeneity and variable selection for standardizing causal effects to a target population. Eur J Epidemiol. 2019;34(12):1119–29.\n\nJagodzinski A, Johansen C, Koch-Gromus U, Aarabi G, Adam G, Anders S, et al. Rationale and design of the Hamburg City Health Study. Eur J Epidemiol. 2020;35(2)169–81.\n\nLatten BGH, Overbeek LIH, Kubat B, Hausen AZ, Schouten LJ. A quarter century of decline of autopsies in the Netherlands. Eur J Epidemiol. 2019;34(12):1171–4.\n\nMuka T, Glisic M, Milic J, Verhoog S, Bohlius J, Bramer W, et al. A 24-step guide on how to design, conduct, and successfully publish a systematic review and meta-analysis in medical research. Eur J Epidemiol. 2020;35(1):49–60.\n\nNilsson A, Bonander C, Stromberg U, Bjork J. Assessing heterogeneous effects and their determinants via estimation of potential outcomes. Eur J Epidemiol. 2019;34(9):823–35.\n\nDahabreh IJ, Hernan MA. Extending inferences from a randomized trial to a target population. Eur J Epidemiol. 2019;34(8):719–22.\n\nDoncarli A, Demiguel V, Canu IG, Goulet V, Bayart S, Calvez T, et al. FranceCoag: a 22-year prospective follow-up of the national French cohort of patients with inherited bleeding disorders. Eur J Epidemiol. 2019;34(5):521–32.\n\nPapatheodorou S. Umbrella reviews: what they are and why we need them. Eur J Epidemiol. 2019;34(6):543–6.\n\nStephan AJ, Strobl R, Schwettmann L, Meisinger C, Ladwig KH, Linkohr B, et al. Being born in the aftermath of World War II increases the risk for health deficit accumulation in older age: results from the KORA-Age study. Eur J Epidemiol. 2019;34(7):675–87.\n\nWaziry R, Gras L, Sedaghat S, Tiemeier H, Weverling GJ, Ghanbari M, et al. Quantification of biological age as a determinant of age-related diseases in the Rotterdam Study: a structural equation modeling approach. Eur J Epidemiol. 2019;34(8):793–9.\n\nWeiss NS. Generalizing from the results of randomized studies of treatment: can non-randomized studies be of help? Eur J Epidemiol. 2019;34(8):715–8.\n\nHoffmann W, Latza U, Baumeister SE, Brunger M, Buttmann-Schweiger N, Hardt J, et al. Guidelines and recommendations for ensuring Good Epidemiological Practice (GEP): a guideline developed by the German Society for Epidemiology. Eur J Epidemiol. 2019;34(3):301–17.\n\nHolstege H, Beker N, Dijkstra T, Pieterse K, Wemmenhove E, Schouten K, et al. The 100-plus study of cognitively healthy centenarians: rationale, design and cohort description. Eur J Epidemiol. 2018;33(12):1229–49.\n\nLudvigsson JF, Svedberg P, Olen O, Bruze G, Neovius M. The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research. Eur J Epidemiol. 2019;34(4):423–37.\n\nMiddeldorp CM, Mahajan A, Horikoshi M, Robertson NR, Beaumont RN, Bradfield JP, et al. The Early Growth Genetics (EGG) and EArly Genetics and Lifecourse Epidemiology (EAGLE) consortia: design, results and future prospects. Eur J Epidemiol. 2019;34(3):279–300.\n\nPadmanabhan S, Carty L, Cameron E, Ghosh RE, Williams R, Strongman H. Approach to record linkage of primary care data from Clinical Practice Research Datalink to other health-related patient data: overview and implications. Eur J Epidemiol. 2019;34(1):91–9.\n\nSillesen AS, Raja AA, Pihl C, Vogg ROB, Hedegaard M, Emmersen P, et al. Copenhagen Baby Heart Study: a population study of newborns with prenatal inclusion. Eur J Epidemiol. 2019;34(1):79–90.\n\nSterner TR, Ahlner F, Blennow K, Dahlin-Ivanoff S, Falk H, Johansson LH, et al. The Gothenburg H70 Birth cohort study 2014–16: design, methods and study population. Eur J Epidemiol. 2019;34(2):191–209.\n\nWiebe T, Hjorth L, Kelly MM, Linge HM, Garwicz S. A population based pediatric oncology registry in Southern Sweden: the BORISS registry. Eur J Epidemiol. 2018;33(11):1125–9.\n\nBliddal M, Broe A, Pottegard A, Olsen J, Langhoff-Roos J. The Danish medical birth register. Eur J Epidemiol. 2018;33(1):27–36.\n\nGrabow D, Kaiser M, Hjorth L, Byrne J, Alessi D, Allodji RS, et al. The PanCareSurFup cohort of 83,333 five-year survivors of childhood cancer: a cohort from 12 European countries. Eur J Epidemiol. 2018;33(3):335–49.\n\nMcDonald L, Schultze A, Carroll R, Ramagopalan SV. Performing studies using the UK Clinical Practice Research Datalink: to link or not to link? Eur J Epidemiol. 2018;33(6):601–5.\n\nFest J, Ruiter R, van Rooij FJ, van der Geest LG, Lemmens VE, Ikram MA, et al. Underestimation of pancreatic cancer in the national cancer registry—reconsidering the incidence and survival rates. Eur J Cancer. 2017;72:186–91.\n\nFest J, Vijfhuizen LS, Goeman JJ, Veth O, Joensuu A, Perola M, et al. Search for early pancreatic cancer blood biomarkers in five european prospective population biobanks using metabolomics. Endocrinology. 2019;160(7):1731–42.\n\nLicher S, Heshmatollah A, van der Willik KD, Stricker BHC, Ruiter R, de Roos EW, et al. Lifetime risk and multimorbidity of non-communicable diseases and disease-free life expectancy in the general population: a population-based cohort study. PLoS Med. 2019;16(2):e1002741.\n\nMarcondes LH, Franco OH, Ruiter R, Ikram MA, Mulder M, Stricker BH, et al. Animal foods and postmenopausal breast cancer risk: a prospective cohort study. Br J Nutr. 2019;5:1–9.\n\nViana Veloso GG, Franco OH, Ruiter R, de Keyser CE, Hofman A, Stricker BC, et al. Baseline dietary glutamic acid intake and the risk of colorectal cancer: the Rotterdam study. Cancer. 2016;122(6):899–907.\n\nMuka T, Kraja B, Ruiter R, de Keyser CE, Hofman A, Stricker BH, et al. Dietary polyunsaturated fatty acids intake modifies the positive association between serum total cholesterol and colorectal cancer risk: the Rotterdam Study. J Epidemiol Comm Health. 2016;70(9):881–7.\n\nMuka T, Kraja B, Ruiter R, Lahousse L, de Keyser CE, Hofman A, et al. Dietary mineral intake and lung cancer risk: the Rotterdam Study. Eur J Nutr. 2017;56(4):1637–46.\n\nOrdonez-Mena JM, Walter V, Schottker B, Jenab M, O'Doherty MG, Kee F, et al. Impact of prediagnostic smoking and smoking cessation on colorectal cancer prognosis: a meta-analysis of individual patient data from cohorts within the CHANCES consortium. Ann Oncol. 2018;29(2):472–83.\n\nOrdonez-Mena JM, Schottker B, Mons U, Jenab M, Freisling H, Bueno-de-Mesquita B, et al. Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium. BMC Med. 2016;14:62.\n\nFest J, Ruiter R, Mooijaart SP, Ikram MA, van Eijck CHJ, Stricker BH. Erythrocyte sedimentation rate as an independent prognostic marker for mortality: a prospective population-based cohort study. J Intern Med. 2019;285(3):341–8.\n\nFest J, Ruiter R, Mulder M, Groot Koerkamp B, Ikram MA, Stricker BH, et al. The systemic immune-inflammation index is associated with an increased risk of incident cancer-A population-based cohort study. Int J Cancer. 2019;146:692–8.\n\nFest J, Ruiter TR, Groot Koerkamp B, Rizopoulos D, Ikram MA, van Eijck CHJ, et al. The neutrophil-to-lymphocyte ratio is associated with mortality in the general population: the Rotterdam Study. Eur J Epidemiol. 2019;34(5):463–70.\n\nvan der Willik KD, Hauptmann M, Jozwiak K, Vinke EJ, Ruiter R, Stricker BH, et al. Trajectories of cognitive function prior to cancer diagnosis: a population-based study. J Natl Cancer Inst. 2019. https://doi.org/10.1093/jnci/djz178.\n\nvan der Willik KD, Ruiter R, Wolters FJ, Ikram MK, Stricker BH, Hauptmann M, et al. Mild cognitive impairment and dementia show contrasting associations with risk of cancer. Neuroepidemiology. 2018;50(3–4):207–15.\n\nVoortman T, Kiefte-de Jong JC, Ikram MA, Stricker BH, van Rooij FJA, Lahousse L, et al. Adherence to the 2015 Dutch dietary guidelines and risk of non-communicable diseases and mortality in the Rotterdam Study. Eur J Epidemiol. 2017;32(11):993–1005.\n\nKhan SR, Chaker L, Ruiter R, Aerts JG, Hofman A, Dehghan A, et al. Thyroid function and cancer risk: the Rotterdam Study. J Clin Endocrinol Metab. 2016;101(12):5030–6.\n\nFest J, Ruiter R, Ikram MA, Voortman T, van Eijck CHJ, Stricker BH. Reference values for white blood-cell-based inflammatory markers in the Rotterdam Study: a population-based prospective cohort study. Sci Rep. 2018;8(1):10566.\n\nWright CM, Moorin RE, Chowdhury EK, Stricker BH, Reid CM, Saunders CM, et al. Calcium channel blockers and breast cancer incidence: an updated systematic review and meta-analysis of the evidence. Cancer Epidemiol. 2017;50(Pt A):113–24.\n\nCote DJ, Rosner BA, Smith-Warner SA, Egan KM, Stampfer MJ. Statin use, hyperlipidemia, and risk of glioma. Eur J Epidemiol. 2019;34(11):997–1011.\n\nHillreiner A, Baumeister SE, Sedlmeier AM, Finger JD, Schlitt HJ, Leitzmann MF. Association between cardiorespiratory fitness and colorectal cancer in the UK Biobank. Eur J Epidemiol. 2019. https://doi.org/10.1007/s10654-019-00575-6.\n\nJeong SM, Lee DH, Giovannucci EL. Predicted lean body mass, fat mass and risk of lung cancer: prospective US cohort study. Eur J Epidemiol. 2019;34(12):1151–60.\n\nLundberg FE, Johansson ALV, Rodriguez-Wallberg K, Gemzell-Danielsson K, Iliadou AN. Assisted reproductive technology and risk of ovarian cancer and borderline tumors in parous women: a population-based cohort study. Eur J Epidemiol. 2019;34(11):1093–101.\n\nRenehan AG, Alam NN, Sperrin M. Interaction between co-morbidities and cancer survival. Eur J Epidemiol. 2019;34(11):1103–5.\n\nSolberg S, Nilssen Y, Brustugun OT, Grimsrud TK, Haram PM, Helbekkmo N, et al. Increase in curative treatment and survival of lung cancer in Norway 2001–2016. Eur J Epidemiol. 2019;34(10):951–5.\n\nTrocchi P, Kuss O, Kaab-Sanyal V, Heidinger O, Stang A. Trends in surgical treatment for breast cancer in Germany after the implementation of the mammography screening program. Eur J Epidemiol. 2019;34(12):1143–50.\n\nvan der Willik KD, Rojas-Saunero LP, Labrecque JA, Ikram MA, Schagen SB, Stricker BH, et al. Pathology-confirmed versus non pathology-confirmed cancer diagnoses: incidence, participant characteristics, and survival. Eur J Epidemiol. 2019. https://doi.org/10.1007/s10654-019-00592-5.\n\nWei YX, Lv J, Guo Y, Bian Z, Gao M, Du HD, et al. Soy intake and breast cancer risk: a prospective study of 300,000 Chinese women and a dose-response meta-analysis. Eur J Epidemiol. 2019. https://doi.org/10.1007/s10654-019-00585-4.\n\nYang TO, Cairns BJ, Green J, Reeves GK, Floud S, Bradbury KE, et al. Adult cancer risk in women who were breastfed as infants: large UK prospective study. Eur J Epidemiol. 2019;34(9):863–70.\n\nBorch KB, Weiderpass E, Braaten T, Hansen MS, Licaj I. Risk of lung cancer and physical activity by smoking status and body mass index, the Norwegian Women and Cancer Study. Eur J Epidemiol. 2019;34(5):489–98.\n\nKar SP, Andrulis IL, Brenner H, Burgess S, Chang-Claude J, Considine D, et al. The association between weight at birth and breast cancer risk revisited using Mendelian randomisation. Eur J Epidemiol. 2019;34(6):591–600.\n\nLundberg FE, Iliadou AN, Rodriguez-Wallberg K, Gemzell-Danielsson K, Johansson ALV. The risk of breast and gynecological cancer in women with a diagnosis of infertility: a nationwide population-based study. Eur J Epidemiol. 2019;34(5):499–507.\n\nSong MY. \"Bad luck\" hypothesis and cancer prevention: translating the debate to more actions. Eur J Epidemiol. 2019;34(5):447–9.\n\nBadrick E, Renehan I, Renehan AG. Linkage of the UK Clinical Practice Research Datalink with the national cancer registry. Eur J Epidemiol. 2019;34(1):101–2.\n\nErren TC, Lewis P. Hypothesis: ubiquitous circadian disruption can cause cancer. Eur J Epidemiol. 2019;34(1):1–4.\n\nKreis C, Doessegger E, Lupatsch JE, Spycher BD. Space-time clustering of childhood cancers: a systematic review and pooled analysis. Eur J Epidemiol. 2019;34(1):9–21.\n\nLeoncini E, Vukovic V, Cadoni G, Giraldi L, Pastorino R, Arzani D, et al. Tumour stage and gender predict recurrence and second primary malignancies in head and neck cancer: a multicentre study within the INHANCE consortium. Eur J Epidemiol. 2018;33(12):1205–18.\n\nLorenz E, Scholz-Kreisel P, Baaken D, Pokora R, Blettner M. Radiotherapy for childhood cancer and subsequent thyroid cancer risk: a systematic review. Eur J Epidemiol. 2018;33(12):1139–62.\n\nMohner M. The Diesel Exhaust in Miners Study provides no evidence for an increase in risk for lung cancer in miners exposed to diesel engine emissions. Eur J Epidemiol. 2018;33(12):1251–4.\n\nSandvei MS, Vatten LJ, Bjelland EK, Eskild A, Hofvind S, Ursin G, et al. Menopausal hormone therapy and breast cancer risk: effect modification by body mass through life. Eur J Epidemiol. 2019;34(3):267–78.\n\nVitellius C, Laly M, Banaszuk AS, Deherce I, Cornet N, Bertrais S, et al. Contribution of the OC Sensor((R)) immunoassay in comparison to the Hemoccult II (R) guaiac-test in organized colorectal cancer screening. Eur J Epidemiol. 2019;34(2):163–72.\n\nWeinstein SJ, Mondul AM, Yu K, Layne TM, Abnet CC, Freedman ND, et al. Circulating 25-hydroxyvitamin D up to 3decades prior to diagnosis in relation to overall and organ-specific cancer survival. Eur J Epidemiol. 2018;33(11):1087–99.\n\nZamora-Ros R, Cayssials V, Jenab M, Rothwell JA, Fedirko V, Aleksandrova K, et al. Dietary intake of total polyphenol and polyphenol classes and the risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Eur J Epidemiol. 2018;33(11):1063–75.\n\nPetridou ET, Georgakis MK, Erdmann F, Ma XM, Heck JE, Auvinen A, et al. Advanced parental age as risk factor for childhood acute lymphoblastic leukemia: results from studies of the Childhood Leukemia International Consortium. Eur J Epidemiol. 2018;33(10):965–76.\n\nCordina-Duverger E, Menegaux F, Popa A, Rabstein S, Harth V, Pesch B, et al. Night shift work and breast cancer: a pooled analysis of population-based case-control studies with complete work history. Eur J Epidemiol. 2018;33(4):369–79.\n\nHabbema D. Statistical analysis and decision making in cancer screening. Eur J Epidemiol. 2018;33(5):433–5.\n\nHanley JA, Njor SH. Disaggregating the mortality reductions due to cancer screening: model-based estimates from population-based data. Eur J Epidemiol. 2018;33(5):465–72.\n\nNiedermaier T, Weigl K, Hoffmeister M, Brenner H. Flexible sigmoidoscopy in colorectal cancer screening: implications of different colonoscopy referral strategies. Eur J Epidemiol. 2018;33(5):473–84.\n\nShield KD, Micallef CM, de Martel C, Heard I, Megraud F, Plummer M, et al. New cancer cases in France in 2015 attributable to infectious agents: a systematic review and meta-analysis. Eur J Epidemiol. 2018;33(3):263–74.\n\nStang A, Jockel KH, Heidinger O. Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000–2015). Eur J Epidemiol. 2018;33(3):303–12.\n\nWong MCS, Chan CH, Cheung W, Fung DH, Liang MY, Huang JLW, et al. Association between investigator-measured body-mass index and colorectal adenoma: a systematic review and meta-analysis of 168,201 subjects. Eur J Epidemiol. 2018;33(1):15–26.\n\nSun YQ, Langhammer A, Wu CS, Skorpen F, Chen Y, Nilsen TIL, et al. Associations of serum 25-hydroxyvitamin D level with incidence of lung cancer and histologic types in Norwegian adults: a case-cohort analysis of the HUNT study. Eur J Epidemiol. 2018;33(1):67–77.\n\nLeening MJ, Kavousi M, Heeringa J, van Rooij FJ, Verkroost-van Heemst J, Deckers JW, et al. Methods of data collection and definitions of cardiac outcomes in the Rotterdam Study. Eur J Epidemiol. 2012;27(3):173–85.\n\nLigthart S, Sedaghat S, Ikram MA, Hofman A, Franco OH, Dehghan A. EN-RAGE: a novel inflammatory marker for incident coronary heart disease. Arterioscler Thromb Vasc Biol. 2014;34(12):2695–9.\n\nBrahimaj A, Ligthart S, Ghanbari M, Ikram MA, Hofman A, Franco OH, et al. Novel inflammatory markers for incident pre-diabetes and type 2 diabetes: the Rotterdam Study. Eur J Epidemiol. 2017;32(3):217–26.\n\nAslibekyan S, Agha G, Colicino E, Do AN, Lahti J, Ligthart S, et al. Association of methylation signals with incident coronary heart disease in an epigenome-wide assessment of circulating tumor necrosis factor alpha. JAMA Cardiol. 2018;3(6):463–72.\n\nBrahimaj A, Ligthart S, Ikram MA, Hofman A, Franco OH, Sijbrands EJ, et al. Serum levels of apolipoproteins and incident type 2 diabetes: a prospective cohort study. Diabetes Care. 2017;40(3):346–51.\n\nBrahimaj A, Rivadeneira F, Muka T, Sijbrands EJG, Franco OH, Dehghan A, et al. Novel metabolic indices and incident type 2 diabetes among women and men: the Rotterdam Study. Diabetologia. 2019;62(9):1581–90.\n\nNano J, Muka T, Ligthart S, Hofman A, Darwish Murad S, Janssen HLA, et al. Gamma-glutamyltransferase levels, prediabetes and type 2 diabetes: a Mendelian randomization study. Int J Epidemiol. 2017;46(5):1400–9.\n\nSonneveld MA, de Maat MP, Portegies ML, Kavousi M, Hofman A, Turecek PL, et al. Low ADAMTS13 activity is associated with an increased risk of ischemic stroke. Blood. 2015;126(25):2739–46.\n\nSonneveld MA, Franco OH, Ikram MA, Hofman A, Kavousi M, de Maat MP, et al. Von willebrand factor, ADAMTS13, and the risk of mortality: the Rotterdam Study. Arterioscler Thromb Vasc Biol. 2016;36(12):2446–511.\n\nSonneveld MA, Kavousi M, Ikram MA, Hofman A, Rueda Ochoa OL, Turecek PL, et al. Low ADAMTS-13 activity and the risk of coronary heart disease—a prospective cohort study: the Rotterdam Study. J Thromb Haemost. 2016;14(11):2114–200.\n\nde Vries PS, van Herpt TT, Ligthart S, Hofman A, Ikram MA, van Hoek M, et al. ADAMTS13 activity as a novel risk factor for incident type 2 diabetes mellitus: a population-based cohort study. Diabetologia. 2017;60(2):280–6.\n\nWard-Caviness CK, de Vries PS, Wiggins KL, Huffman JE, Yanek LR, Bielak LF, et al. Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease. PLoS ONE. 2019;14(5):e0216222.\n\nRoselli C, Chaffin MD, Weng LC, Aeschbacher S, Ahlberg G, Albert CM, et al. Multi-ethnic genome-wide association study for atrial fibrillation. Nat Genet. 2018;50(9):1225–333.\n\nLiu CT, Merino J, Rybin D, DiCorpo D, Benke KS, Bragg-Gresham JL, et al. Genome-wide Association Study of Change in Fasting Glucose over time in 13,807 non-diabetic European Ancestry Individuals. Sci Rep. 2019;9(1):9439.\n\nWild PS, Felix JF, Schillert A, Teumer A, Chen MH, Leening MJG, et al. Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function. J Clin Invest. 2017;127(5):1798–812.\n\nLiu J, Carnero-Montoro E, van Dongen J, Lent S, Nedeljkovic I, Ligthart S, et al. An integrative cross-omics analysis of DNA methylation sites of glucose and insulin homeostasis. Nat Commun. 2019;10(1):2581.\n\nLigthart S, Steenaard RV, Peters MJ, van Meurs JB, Sijbrands EJ, Uitterlinden AG, et al. Tobacco smoking is associated with DNA methylation of diabetes susceptibility genes. Diabetologia. 2016;59(5):998–1006.\n\nt Hart LM, Vogelzangs N, Mook-Kanamori DO, Brahimaj A, Nano J, van der Heijden A, et al. Blood metabolomic measures associate with present and future glycemic control in type 2 diabetes. J Clin Endocrinol Metab. 2018;103(12):4569–79.\n\nSung YJ, de Las FL, Winkler TW, Chasman DI, Bentley AR, Kraja AT, et al. A multi-ancestry genome-wide study incorporating gene-smoking interactions identifies multiple new loci for pulse pressure and mean arterial pressure. Hum Mol Genet. 2019;28:2615–33.\n\nSung YJ, Winkler TW, de Las FL, Bentley AR, Brown MR, Kraja AT, et al. A large-scale multi-ancestry genome-wide study accounting for smoking behavior identifies multiple significant loci for blood pressure. Am J Hum Genet. 2018;102(3):375–400.\n\nWeng LC, Lunetta KL, Muller-Nurasyid M, Smith AV, Theriault S, Weeke PE, et al. Genetic interactions with age, sex, body mass index, and hypertension in relation to atrial fibrillation: the AFGen consortium. Sci Rep. 2017;7(1):11303.\n\nLeening MJ, Ferket BS, Steyerberg EW, Kavousi M, Deckers JW, Nieboer D, et al. Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study. BMJ. 2014;349:g5992.\n\nKavousi M, Desai CS, Ayers C, Blumenthal RS, Budoff MJ, Mahabadi AA, et al. Prevalence and prognostic implications of coronary artery calcification in low-risk women: a meta-analysis. JAMA. 2016;316(20):2126–34.\n\nJaspers L, Dhana K, Muka T, Meun C, Kiefte-de Jong JC, Hofman A, et al. Sex steroids, sex hormone-binding globulin and cardiovascular health in men and postmenopausal women: the Rotterdam Study. J Clin Endocrinol Metab. 2016;101(7):2844–52.\n\nGlisic M, Mujaj B, Rueda-Ochoa OL, Asllanaj E, Laven JSE, Kavousi M, et al. Associations of endogenous estradiol and testosterone levels with plaque composition and risk of stroke in subjects with carotid atherosclerosis. Circ Res. 2018;122(1):97–105.\n\nBrahimaj A, Muka T, Kavousi M, Laven JS, Dehghan A, Franco OH. Serum dehydroepiandrosterone levels are associated with lower risk of type 2 diabetes: the Rotterdam Study. Diabetologia. 2017;60(1):98–106.\n\nMuka T, Nano J, Jaspers L, Meun C, Bramer WM, Hofman A, et al. Associations of steroid sex hormones and sex hormone-binding globulin with the risk of type 2 diabetes in women: a population-based cohort study and meta-analysis. Diabetes. 2017;66(3):577–86.\n\nDaan NM, Jaspers L, Koster MP, Broekmans FJ, de Rijke YB, Franco OH, et al. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features. Hum Reprod. 2015;30(10):2376–86.\n\nDaan NM, Muka T, Koster MP, Roeters van Lennep JE, Lambalk CB, Laven JS, et al. Cardiovascular risk in women with premature ovarian insufficiency compared to premenopausal women at middle age. J Clin Endocrinol Metab. 2016;101(9):3306–15.\n\nMeun C, Franco OH, Dhana K, Jaspers L, Muka T, Louwers Y, et al. High androgens in postmenopausal women and the risk for atherosclerosis and cardiovascular disease: the Rotterdam Study. J Clin Endocrinol Metab. 2018;103(4):1622–30.\n\nMuka T, Asllanaj E, Avazverdi N, Jaspers L, Stringa N, Milic J, et al. Age at natural menopause and risk of type 2 diabetes: a prospective cohort study. Diabetologia. 2017;60(10):1951–60.\n\nAsllanaj E, Bano A, Glisic M, Jaspers L, Ikram MA, Laven JSE, et al. Age at natural menopause and life expectancy with and without type 2 diabetes. Menopause. 2019;26(4):387–94.\n\nSarnowski C, Kavousi M, Isaacs S, Demerath EW, Broer L, Muka T, et al. Genetic variants associated with earlier age at menopause increase the risk of cardiovascular events in women. Menopause. 2018;25(4):451–7.\n\nRueda-Ochoa OL, Smiderle-Gelain MA, Rizopoulos D, Dhana K, van den Berge JK, Echeverria LE, et al. Risk factors for longitudinal changes in left ventricular diastolic function among women and men. Heart. 2019;105(18):1414–22.\n\nJaspers L, Schoufour JD, Erler NS, Darweesh SK, Portegies ML, Sedaghat S, et al. Development of a healthy aging score in the population-based rotterdam study: evaluating age and sex differences. J Am Med Dir Assoc. 2017;18(3):276e1–e7.\n\nJaspers L, Kavousi M, Erler NS, Hofman A, Laven JS, Franco OH. Fertile lifespan characteristics and all-cause and cause-specific mortality among postmenopausal women: the Rotterdam Study. Fertil Steril. 2017;107(2):448–56e1.\n\nHeeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27(8):949–53.\n\nLigthart S, van Herpt TT, Leening MJ, Kavousi M, Hofman A, Stricker BH, et al. Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study. Lancet Diabetes Endocrinol. 2016;4(1):44–51.\n\nKavousi M, Leening MJ, Nanchen D, Greenland P, Graham IM, Steyerberg EW, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort. JAMA. 2014;311(14):1416–23.\n\nKavousi M, Elias-Smale S, Rutten JH, Leening MJ, Vliegenthart R, Verwoert GC, et al. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann Intern Med. 2012;156(6):438–44.\n\nYano Y, O'Donnell CJ, Kuller L, Kavousi M, Erbel R, Ning H, et al. Association of coronary artery calcium score vs age with cardiovascular risk in older adults: an analysis of pooled population-based studies. JAMA Cardiol. 2017;2(9):986–94.\n\nPennells L, Kaptoge S, Wood A, Sweeting M, Zhao X, White I, et al. Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies. Eur Heart J. 2019;40(7):621–31.\n\nGroup WCRCW. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Glob Health. 2019;7:1332–455.\n\nDhana K, Ikram MA, Hofman A, Franco OH, Kavousi M. Anthropometric measures in cardiovascular disease prediction: comparison of laboratory-based versus non-laboratory-based model. Heart. 2015;101(5):377–83.\n\nPaige E, Barrett J, Pennells L, Sweeting M, Willeit P, Di Angelantonio E, et al. Use of repeated blood pressure and cholesterol measurements to improve cardiovascular disease risk prediction: an individual-participant-data meta-analysis. Am J Epidemiol. 2017;186(8):899–907.\n\nCho IJ, Sung JM, Kim HC, Lee SE, Chae MH, Kavousi M, et al. Development and External Validation of a Deep Learning Algorithm for Prognostication of Cardiovascular Outcomes. Korean Circ J. 2019;50:72–84.\n\nWen KX, Ikram MA, Franco OH, Vernooij M, MaassenVanDenBrink A, Bos D, et al. Association of migraine with calcification in major vessel beds: the Rotterdam Study. Cephalalgia. 2019;39(8):1041–8.\n\nSedaghat S, Hoorn EJ, Ikram MA, Koop-Nieuwelink C, Kavousi M, Franco OH, et al. Kidney function and arterial calcification in major vascular beds. J Am Heart Assoc. 2019;8(9):e010930.\n\nChen LY, Leening MJ, Norby FL, Roetker NS, Hofman A, Franco OH, et al. Carotid intima-media thickness and arterial stiffness and the risk of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) Study, Multi-Ethnic Study of Atherosclerosis (MESA), and the Rotterdam Study. J Am Heart Assoc. 2016;5(5):002907. https://doi.org/10.1161/JAHA.115.002907.\n\nBos D, Vernooij MW, Shahzad R, Kavousi M, Hofman A, van Walsum T, et al. Epicardial fat volume and the risk of atrial fibrillation in the general population free of cardiovascular disease. JACC Cardiovasc Imaging. 2017;10(11):1405–7.\n\nCroll PH, Bos D, Vernooij MW, Arshi B, Lin FR, Baatenburg de Jong RJ, et al. Carotid atherosclerosis is associated with poorer hearing in older adults. J Am Med Dir Assoc. 2019;20(12):1617–22e1.\n\nSedaghat S, van Sloten TT, Laurent S, London GM, Pannier B, Kavousi M, et al. Common carotid artery diameter and risk of cardiovascular events and mortality: pooled analyses of four cohort studies. Hypertension. 2018;72(1):85–92.\n\nLorenz MW, Gao L, Ziegelbauer K, Norata GD, Empana JP, Schmidtmann I, et al. Predictive value for cardiovascular events of common carotid intima media thickness and its rate of change in individuals at high cardiovascular risk—results from the PROG-IMT collaboration. PLoS ONE. 2018;13(4):e0191172.\n\nNilsson PM, Laurent S, Cunha PG, Olsen MH, Rietzschel E, Franco OH, et al. Characteristics of healthy vascular ageing in pooled population-based cohort studies: the global Metabolic syndrome and Artery REsearch Consortium. J Hypertens. 2018;36(12):2340–9.\n\nMujaj B, Bos D, Selwaness M, Leening MJG, Kavousi M, Wentzel JJ, et al. Statin use is associated with carotid plaque composition: the Rotterdam Study. Int J Cardiol. 2018;260:213–8.\n\nvan den Bouwhuijsen QJ, Selwaness M, Tang H, Niessen WJ, Hofman A, Franco OH, et al. Change in carotid intraplaque hemorrhage in community-dwelling subjects: a follow-up study using serial MR imaging. Radiology. 2017;282(2):526–33.\n\nMujaj B, Bos D, Muka T, Lugt AV, Ikram MA, Vernooij MW, et al. Antithrombotic treatment is associated with intraplaque haemorrhage in the atherosclerotic carotid artery: a cross-sectional analysis of The Rotterdam Study. Eur Heart J. 2018;39(36):3369–76.\n\nFranceschini N, Giambartolomei C, de Vries PS, Finan C, Bis JC, Huntley RP, et al. GWAS and colocalization analyses implicate carotid intima-media thickness and carotid plaque loci in cardiovascular outcomes. Nat Commun. 2018;9(1):5141.\n\nNatarajan P, Bis JC, Bielak LF, Cox AJ, Dorr M, Feitosa MF, et al. Multiethnic exome-wide association study of subclinical atherosclerosis. Circ Cardiovasc Genet. 2016;9(6):511–20.\n\nTzoulaki I, Castagne R, Boulange CL, Karaman I, Chekmeneva E, Evangelou E, et al. Serum metabolic signatures of coronary and carotid atherosclerosis and subsequent cardiovascular disease. Eur Heart J. 2019;40(34):2883–96.\n\nVojinovic D, van der Lee SJ, van Duijn CM, Vernooij MW, Kavousi M, Amin N, et al. Metabolic profiling of intra- and extracranial carotid artery atherosclerosis. Atherosclerosis. 2018;272:60–5.\n\nGabet A, Chatignoux E, Billionnet C, Maura G, Giroud M, Bejot Y, et al. Annual rate of newly treated atrial fibrillation by age and gender in France, 2010–2016. Eur J Epidemiol. 2019. https://doi.org/10.1007/s10654-019-00594-3.\n\nKunutsor SK, Mäkikallio TH, Khan H, Laukkanen T, Kauhanen J, Laukkanen JA. Sauna bathing reduces the risk of venous thromboembolism: a prospective cohort study. Eur J Epidemiol. 2019;34(10):983–6.\n\nWu L, Lin HD, Hu Y, Zhu CW, Ma H, Gao J, et al. The major causes and risk factors of total and cause-specific mortality during 5.4-year follow-up: the Shanghai Changfeng Study. Eur J Epidemiol. 2019;34(10):939–49.\n\nFest J, Ruiter TR, Koerkamp BG, Rizopoulos D, Ikram MA, van Eijck CHJ, et al. The neutrophil-to-lymphocyte ratio is associated with mortality in the general population: the Rotterdam Study. Eur J Epidemiol. 2019;34(5):463–70.\n\nHamer M, O'Donovan G, Stamatakis E. Association between physical activity and sub-types of cardiovascular disease death causes in a general population cohort. Eur J Epidemiol. 2019;34(5):483–7.\n\nKobeissi E, Hibino M, Pan H, Aune D. Blood pressure, hypertension and the risk of abdominal aortic aneurysms: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 2019;34(6):547–55.\n\nXuan Y, Bobak M, Anusruti A, Jansen E, Pajak A, Tamosiunas A, et al. Association of serum markers of oxidative stress with myocardial infarction and stroke: pooled results from four large European cohort studies. Eur J Epidemiol. 2019;34(5):471–81.\n\nMeier T, Grafe K, Senn F, Sur P, Stangl GI, Dawczynski C, et al. Cardiovascular mortality attributable to dietary risk factors in 51 countries in the WHO European Region from 1990 to 2016: a systematic analysis of the Global Burden of Disease Study. Eur J Epidemiol. 2019;34(1):37–55.\n\nZhu DS, Chung HF, Pandeya N, Dobson AJ, Hardy R, Kuh D, et al. Premenopausal cardiovascular disease and age at natural menopause: a pooled analysis of over 170,000 women. Eur J Epidemiol. 2019;34(3):235–46.\n\nAune D, Schlesinger S, Norat T, Riboli E. Body mass index, abdominal fatness, and the risk of sudden cardiac death: a systematic review and dose-response meta-analysis of prospective studies. Eur J Epidemiol. 2018;33(8):711–22.\n\nAune D, Schlesinger S, Norat T, Riboli E. Tobacco smoking and the risk of sudden cardiac death: a systematic review and meta-analysis of prospective studies. Eur J Epidemiol. 2018;33(6):509–21.\n\nBergen NE, Schalekamp-Timmermans S, van Lennep JER, Jaddoe VVW, Steegers EAP. Hypertensive disorders of pregnancy and subsequent maternal cardiovascular health. Eur J Epidemiol. 2018;33(8):763–71.\n\nHaug EB, Horn J, Markovitz AR, Fraser A, Macdonald-Wallis C, Tilling K, et al. The impact of parity on life course blood pressure trajectories: the HUNT study in Norway. Eur J Epidemiol. 2018;33(8):751–61.\n\nTimpka S, Fraser A, Schyman T, Stuart JJ, Asvold BO, Mogren I, et al. The value of pregnancy complication history for 10-year cardiovascular disease risk prediction in middle-aged women. Eur J Epidemiol. 2018;33(10):1003–100.\n\nWannamethee SG, Papacosta O, Lennon L, Whincup PH. Serum magnesium and risk of incident heart failure in older men: the British Regional Heart Study. Eur J Epidemiol. 2018;33(9):873–82.\n\nBillar RJ, Leening MJG, Merkus D, Brusselle GGO, Hofman A, Stricker BHC, et al. Measures of subclinical cardiac dysfunction and increased filling pressures associate with pulmonary arterial pressure in the general population: results from the population-based Rotterdam Study. Eur J Epidemiol. 2018;33(4):403–13.\n\nFloegel A, Kuhn T, Sookthai D, Johnson T, Prehn C, Rolle-Kampczyk U, et al. Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two German prospective cohorts. Eur J Epidemiol. 2018;33(1):55–66.\n\nHantikainen E, Lof M, Grotta A, Lagerros YT, Serafini M, Bellocco R, et al. Dietary non enzymatic antioxidant capacity and the risk of myocardial infarction in the Swedish women's lifestyle and health cohort. Eur J Epidemiol. 2018;33(2):213–21.\n\nJones NRV, Forouhi NG, Khaw KT, Wareham NJ, Monsivais P. Accordance to the Dietary Approaches to Stop Hypertension diet pattern and cardiovascular disease in a British, population-based cohort. Eur J Epidemiol. 2018;33(2):235–44.\n\nPardo LM, Li WQ, Hwang SJ, Verkouteren JA, Hofman A, Uitterlinden AG, et al. Genome-wide association studies of multiple keratinocyte cancers. PLoS ONE. 2017;12(1):e0169873.\n\nSmedinga H, Verkouteren JAC, Steyerberg EW, Hofman A, Nijsten T, Vergouwe Y. Occurrence of metachronous basal cell carcinomas: a prognostic model. Br J Dermatol. 2017;177(4):1113–21.\n\nDuffy DL, Zhu G, Li X, Sanna M, Iles MM, Jacobs LC, et al. Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways. Nat Commun. 2018;9(1):4774.\n\nJacobs LC, Liu F, Pardo LM, Hofman A, Uitterlinden AG, Kayser M, et al. IRF4, MC1R and TYR genes are risk factors for actinic keratosis independent of skin color. Hum Mol Genet. 2015;24(11):3296–303.\n\nTagliabue E, Fargnoli MC, Gandini S, Maisonneuve P, Liu F, Kayser M, et al. MC1R gene variants and non-melanoma skin cancer: a pooled-analysis from the M-SKIP project. Br J Cancer. 2015;113(2):354–63.\n\nZhong K, Verkouteren JAC, Jacobs LC, Uitterlinden AG, Hofman A, Liu F, et al. Pigmentation-independent susceptibility loci for actinic keratosis highlighted by compound heterozygosity analysis. J Invest Dermatol. 2017;137(1):77–84.\n\nLiu F, Hamer MA, Heilmann S, Herold C, Moebus S, Hofman A, et al. Prediction of male-pattern baldness from genotypes. Eur J Hum Genet. 2016;24(6):895–902.\n\nLiu F, Hamer MA, Deelen J, Lall JS, Jacobs L, van Heemst D, et al. The MC1R gene and youthful looks. Curr Biol. 2016;26(9):1213–20.\n\nZhong K, Zhu G, Jing X, Hendriks AEJ, Drop SLS, Ikram MA, et al. Genome-wide compound heterozygote analysis highlights alleles associated with adult height in Europeans. Hum Genet. 2017;136(11–12):1407–17.\n\nHysi PG, Valdes AM, Liu F, Furlotte NA, Evans DM, Bataille V, et al. Genome-wide association meta-analysis of individuals of European ancestry identifies new loci explaining a substantial fraction of hair color variation and heritability. Nat Genet. 2018;50(5):652–6.\n\nLiu F, Chen Y, Zhu G, Hysi PG, Wu S, Adhikari K, et al. Meta-analysis of genome-wide association studies identifies 8 novel loci involved in shape variation of human head hair. Hum Mol Genet. 2018;27(3):559–75.\n\nVisconti A, Duffy DL, Liu F, Zhu G, Wu W, Chen Y, et al. Genome-wide association study in 176,678 Europeans reveals genetic loci for tanning response to sun exposure. Nat Commun. 2018;9(1):1684.\n\nWu S, Zhang M, Yang X, Peng F, Zhang J, Tan J, et al. Genome-wide association studies and CRISPR/Cas9-mediated gene editing identify regulatory variants influencing eyebrow thickness in humans. PLoS Genet. 2018;14(9):e1007640.\n\nPeng F, Zhu G, Hysi PG, Eller RJ, Chen Y, Li Y, et al. Genome-wide association studies identify multiple genetic loci influencing eyebrow color variation in Europeans. J Invest Dermatol. 2019;139(7):1601–5.\n\nHamer MA, Pardo LM, Jacobs LC, Ikram MA, Laven JS, Kayser M, et al. Lifestyle and physiological factors associated with facial wrinkling in men and women. J Invest Dermatol. 2017;137(8):1692–9.\n\nHamer MA, Pardo LM, Jacobs LC, Deelen J, Uitterlinden AG, Slagboom E, et al. Facial wrinkles in Europeans: a Genome-Wide Association Study. J Invest Dermatol. 2018;138(8):1877–80.\n\nMekic S, Jacobs LC, Hamer MA, Ikram MA, Schoufour JD, Gunn DA, et al. A healthy diet in women is associated with less facial wrinkles in a large Dutch population-based cohort. J Am Acad Dermatol. 2019;80(5):1358–63.\n\nPardo LM, Hamer MA, Liu F, Velthuis P, Kayser M, Gunn DA, et al. Principal component analysis of seven skin ageing features identifies three main types of skin ageing. Br J Dermatol. 2019. https://doi.org/10.1111/bjd.18523.\n\nSanders MGH, Pardo LM, Franco OH, Ginger RS, Nijsten T. Prevalence and determinants of seborrhoeic dermatitis in a middle-aged and elderly population: the Rotterdam Study. Br J Dermatol. 2018;178(1):148–53.\n\nSanders MGH, Pardo LM, Uitterlinden AG, Smith AM, Ginger RS, Nijsten T. The genetics of seborrheic dermatitis: a candidate gene approach and pilot Genome-Wide Association Study. J Invest Dermatol. 2018;138(4):991–3.\n\nAune D, Snekvik I, Schlesinger S, Norat T, Riboli E, Vatten LJ. Body mass index, abdominal fatness, weight gain and the risk of psoriasis: a systematic review and dose-response meta-analysis of prospective studies. Eur J Epidemiol. 2018;33(12):1163–78.\n\nChaker L, van den Berg ME, Niemeijer MN, Franco OH, Dehghan A, Hofman A, et al. Thyroid function and sudden cardiac death: a prospective population-based cohort study. Circulation. 2016;134(10):713–22.\n\nBano A, Chaker L, Mattace-Raso FUS, van der Lugt A, Ikram MA, Franco OH, et al. Thyroid function and the risk of atherosclerotic cardiovascular morbidity and mortality: the Rotterdam Study. Circ Res. 2017;121(12):1392–400.\n\nChaker L, Wolters FJ, Bos D, Korevaar TI, Hofman A, van der Lugt A, et al. Thyroid function and the risk of dementia: the Rotterdam Study. Neurology. 2016;87(16):1688–95.\n\nBano A, Chaker L, Schoufour J, Ikram MA, Kavousi M, Franco OH, et al. High circulating free thyroxine levels may increase the risk of frailty: the Rotterdam Study. J Clin Endocrinol Metab. 2018;103(1):328–35.\n\nChaker L, Ligthart S, Korevaar TI, Hofman A, Franco OH, Peeters RP, et al. Thyroid function and risk of type 2 diabetes: a population-based prospective cohort study. BMC Med. 2016;14(1):150.\n\nBano A, Chaker L, de Maat MPM, Atiq F, Kavousi M, Franco OH, et al. Thyroid function and cardiovascular disease: the mediating role of coagulation factors. J Clin Endocrinol Metab. 2019;104(8):3203–12.\n\nBano A, Dhana K, Chaker L, Kavousi M, Ikram MA, Mattace-Raso FUS, et al. Association of thyroid function with life expectancy with and without cardiovascular disease: the Rotterdam Study. JAMA Intern Med. 2017;177(11):1650–7.\n\nTeumer A, Chaker L, Groeneweg S, Li Y, Di Munno C, Barbieri C, et al. Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation. Nat Commun. 2018;9(1):4455.\n\nChaker L, Cappola AR, Mooijaart SP, Peeters RP. Clinical aspects of thyroid function during ageing. Lancet Diabetes Endocrinol. 2018;6(9):733–42.\n\nChaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017;390(10101):1550–622.\n\nPeeters RP. Subclinical hypothyroidism. N Engl J Med. 2017;376(26):2556–655.\n\nKoop-Nieuwelink C, Sedaghat S, Mutlu U, Licher S, Franco OH, Ikram MA, et al. Kidney function and the risk of stroke and dementia: the Rotterdam Study. J Alzheimers Dis. 2019;67(3):821–6.\n\nSedaghat S, Vernooij MW, Loehrer E, Mattace-Raso FU, Hofman A, van der Lugt A, et al. Kidney function and cerebral blood flow: the Rotterdam Study. J Am Soc Nephrol. 2016;27(3):715–21.\n\nSedaghat S, Cremers LG, de Groot M, Hoorn EJ, Hofman A, van der Lugt A, et al. Kidney function and microstructural integrity of brain white matter. Neurology. 2015;85(2):154–61.\n\nSedaghat S, de Vries PS, Boender J, Sonneveld MA, Hoorn EJ, Hofman A, et al. von Willebrand factor, ADAMTS13 activity, and decline in kidney function: a population-based cohort study. Am J Kidney Dis. 2016;68(5):726–32.\n\nLi WZ, Chen ZL, Ruan WY, Yi GL, Wang DM, Lu ZX. A meta-analysis of cohort studies including dose-response relationship between shift work and the risk of diabetes mellitus. Eur J Epidemiol. 2019;34(11):1013–24.\n\nNeuenschwander M, Hoffmann G, Schwingshackl L, Schlesinger S. Impact of different dietary approaches on blood lipid control in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis. Eur J Epidemiol. 2019;34(9):837–52.\n\nvan der Schaft N, Schoufour JD, Nano J, Kiefte-de Jong JC, Muka T, Sijbrands EJG, et al. Dietary antioxidant capacity and risk of type 2 diabetes mellitus, prediabetes and insulin resistance: the Rotterdam Study. Eur J Epidemiol. 2019;34(9):853–61.\n\nChen JL, van der Duin D, Campos-Obando N, Ikram MA, Nijsten TEC, Uitterlinden AG, et al. Serum 25-hydroxyvitamin D-3 is associated with advanced glycation end products (AGEs) measured as skin autofluorescence: the Rotterdam Study. Eur J Epidemiol. 2019;34(1):67–77.\n\nChoi YJ, Lee DH, Han KD, Shin CM, Kim N. Abdominal obesity, glucose intolerance and decreased high-density lipoprotein cholesterol as components of the metabolic syndrome are associated with the development of colorectal cancer. Eur J Epidemiol. 2018;33(11):1077–85.\n\nHuth C, von Toerne C, Schederecker F, Gala TD, Herder C, Kronenberg F, et al. Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study. Eur J Epidemiol. 2019;34(4):409–22.\n\nSaarela K, Tuomilehto J, Sund R, Keskimaki I, Hartikainen S, Pukkala E. Cancer incidence among Finnish people with type 2 diabetes during 1989–2014. Eur J Epidemiol. 2019;34(3):259–65.\n\nAune D, Mahamat-Saleh Y, Norat T, Riboli E. Body fatness, diabetes, physical activity and risk of kidney stones: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 2018;33(11):1033–47.\n\nChen ZL, Zuurmond MG, van der Schaft N, Nano J, Wijnhoven HAH, Ikram MA, et al. Plant versus animal based diets and insulin resistance, prediabetes and type 2 diabetes: the Rotterdam Study. Eur J Epidemiol. 2018;33(9):883–93.\n\nLee DH, Keum N, Hu FB, Orav EJ, Rimm EB, Willett WC, et al. Comparison of the association of predicted fat mass, body mass index, and other obesity indicators with type 2 diabetes risk: two large prospective studies in US men and women. Eur J Epidemiol. 2018;33(11):1113–23.\n\nVinceti M, Filippini T, Rothman KJ. Selenium exposure and the risk of type 2 diabetes: a systematic review and meta-analysis. Eur J Epidemiol. 2018;33(9):789–810.\n\nSchwingshackl L, Chaimani A, Hoffmann G, Schwedhelm C, Boeing H. A network meta-analysis on the comparative efficacy of different dietary approaches on glycaemic control in patients with type 2 diabetes mellitus. Eur J Epidemiol. 2018;33(2):157–70.\n\nIkram MA, Brusselle GGO, Murad SD, van Duijn CM, Franco OH, Goedegebure A, et al. The Rotterdam Study: 2018 update on objectives, design and main results. Eur J Epidemiol. 2017;32(9):807–50.\n\nFlorio AA, Graubard BI, Yang B, Thistle JE, Bradley MC, McGlynn KA, et al. Oophorectomy and risk of non-alcoholic fatty liver disease and primary liver cancer in the Clinical Practice Research Datalink. Eur J Epidemiol. 2019;34(9):871–8.\n\nMarild K, Tapia G, Midttun O, Ueland PM, Magnus MC, Rewers M, et al. Smoking in pregnancy, cord blood cotinine and risk of celiac disease diagnosis in offspring. Eur J Epidemiol. 2019;34(7):637–49.\n\nOtt A, Breteler MM, van Harskamp F, Claus JJ, van der Cammen TJ, Grobbee DE, et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ. 1995;310(6985):970–3.\n\nRuitenberg A, Ott A, van Swieten JC, Hofman A, Breteler MM. Incidence of dementia: does gender make a difference? Neurobiol Aging. 2001;22(4):575–80.\n\nde Rijk MC, Breteler MM, Graveland GA, Ott A, Grobbee DE, van der Meche FG, et al. Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology. 1995;45(12):2143–6.\n\nBos MJ, Schipper CM, Koudstaal PJ, Witteman JC, Hofman A, Breteler MM. High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study. Circulation. 2006;114(15):1591–8.\n\nBos MJ, van Rijn MJ, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM. Incidence and prognosis of transient neurological attacks. JAMA. 2007;298(24):2877–85.\n\nHollander M, Koudstaal PJ, Bots ML, Grobbee DE, Hofman A, Breteler MM. Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study. J Neurol Neurosurg Psychiatry. 2003;74(3):317–21.\n\nIkram MA, van der Lugt A, Niessen WJ, Krestin GP, Koudstaal PJ, Hofman A, et al. The Rotterdam Scan Study: design and update up to 2012. Eur J Epidemiol. 2011;26(10):811–24.\n\nHoogendam YY, Hofman A, van der Geest JN, van der Lugt A, Ikram MA. Patterns of cognitive function in aging: the Rotterdam Study. Eur J Epidemiol. 2014;29(2):133–40.\n\nKillgore WD, Glahn DC, Casasanto DJ. Development and Validation of the Design Organization Test (DOT): a rapid screening instrument for assessing visuospatial ability. J Clin Exp Neuropsychol. 2005;27(4):449–59.\n\nTrouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K, et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci. 1997;145(2):205–11.\n\nVerlinden VJ, van der Geest JN, Hoogendam YY, Hofman A, Breteler MM, Ikram MA. Gait patterns in a community-dwelling population aged 50 years and older. Gait Posture. 2013;37(4):500–5.\n\nHanewinckel R, Drenthen J, van Oijen M, Hofman A, van Doorn PA, Ikram MA. Prevalence of polyneuropathy in the general middle-aged and elderly population. Neurology. 2016;87(18):1892–8.\n\nLicher S, Darweesh SKL, Wolters FJ, Fani L, Heshmatollah A, Mutlu U, et al. Lifetime risk of common neurological diseases in the elderly population. J Neurol Neurosurg Psychiatry. 2019;90(2):148–56.\n\nWolters FJ, Tinga LM, Dhana K, Koudstaal PJ, Hofman A, Bos D, et al. Life Expectancy with and without dementia: a population-based study of dementia burden and preventive potential. Am J Epidemiol. 2019;188(2):372–81.\n\nLicher S, Ahmad S, Karamujic-Comic H, Voortman T, Leening MJG, Ikram MA, et al. Genetic predisposition, modifiable-risk-factor profile and long-term dementia risk in the general population. Nat Med. 2019;25(9):1364–9.\n\nvan der Lee SJ, Wolters FJ, Ikram MK, Hofman A, Ikram MA, Amin N, et al. The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study. Lancet Neurol. 2018;17(5):434–44.\n\nLicher S, Yilmaz P, Leening MJG, Wolters FJ, Vernooij MW, Stephan BCM, et al. External validation of four dementia prediction models for use in the general community-dwelling population: a comparative analysis from the Rotterdam Study. Eur J Epidemiol. 2018;33(7):645–55.\n\nLicher S, Leening MJG, Yilmaz P, Wolters FJ, Heeringa J, Bindels PJE, et al. Development and validation of a dementia risk prediction model in the general population: an analysis of three longitudinal studies. Am J Psychiatry. 2019;176(7):543–51.\n\nSims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet. 2017;49(9):1373–84.\n\nWolters FJ, Zonneveld HI, Hofman A, van der Lugt A, Koudstaal PJ, Vernooij MW, et al. Cerebral perfusion and the risk of dementia: a population-based study. Circulation. 2017;136(8):719–28.\n\nWolters FJ, van der Lee SJ, Koudstaal PJ, van Duijn CM, Hofman A, Ikram MK, et al. Parental family history of dementia in relation to subclinical brain disease and dementia risk. Neurology. 2017;88(17):1642–9.\n\nLicher S, van der Willik KD, Vinke EJ, Yilmaz P, Fani L, Schagen SB, et al. Alzheimer's disease as a multistage process: an analysis from a population-based cohort study. Aging (Albany NY). 2019;11(4):1163–76.\n\nMutlu U, Colijn JM, Ikram MA, Bonnemaijer PWM, Licher S, Wolters FJ, et al. Association of retinal neurodegeneration on optical coherence tomography with dementia: a population-based study. JAMA Neurol. 2018;75(10):1256–63.\n\nDarweesh SKL, Licher S, Wolters FJ, Koudstaal PJ, Ikram MK, Ikram MA. Quantitative gait, cognitive decline, and incident dementia: The Rotterdam Study. Alzheimers Dement. 2019;15:1264–73.\n\nFani L, Bos D, Mutlu U, Portegies MLP, Zonneveld HI, Koudstaal PJ, et al. Global brain perfusion and the risk of transient ischemic attack and ischemic stroke: the Rotterdam Study. J Am Heart Assoc. 2019;8(7):e011565.\n\nMutlu U, Swanson SA, Klaver CCW, Hofman A, Koudstaal PJ, Ikram MA, et al. The mediating role of the venules between smoking and ischemic stroke. Eur J Epidemiol. 2018;33(12):1219–28.\n\nBerghout BP, Fani L, Heshmatollah A, Koudstaal PJ, Ikram MA, Zillikens MC, et al. Vitamin D status and risk of stroke. Stroke. 2019;50(9):2293–8.\n\nBos D, Ikram MA, Leening MJG, Ikram MK. The revised framingham stroke risk profile in a primary prevention population: the Rotterdam Study. Circulation. 2017;135(22):2207–9.\n\nLysen TS, Darweesh SKL, Ikram MK, Luik AI, Ikram MA. Sleep and risk of parkinsonism and Parkinson's disease: a population-based study. Brain. 2019;142(7):2013–22.\n\nDarweesh SKL, Wolters FJ, Postuma RB, Stricker BH, Hofman A, Koudstaal PJ, et al. Association between poor cognitive functioning and risk of incident parkinsonism: the Rotterdam Study. JAMA Neurol. 2017;74(12):1431–8.\n\nDarweesh SK, Verlinden VJ, Stricker BH, Hofman A, Koudstaal PJ, Ikram MA. Trajectories of prediagnostic functioning in Parkinson's disease. Brain. 2017;140(Pt 2):429–41.\n\nKunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet. 2019;51(3):414–30.\n\nChauhan G, Adams HHH, Satizabal CL, Bis JC, Teumer A, Sargurupremraj M, et al. Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting. Neurology. 2019;92:e486–e503.\n\nVojinovic D, Adams HH, Jian X, Yang Q, Smith AV, Bis JC, et al. Genome-wide association study of 23,500 individuals identifies 7 loci associated with brain ventricular volume. Nat Commun. 2018;9(1):3945.\n\nMalik R, Chauhan G, Traylor M, Sargurupremraj M, Okada Y, Mishra A, et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet. 2018;50(4):524–37.\n\nHibar DP, Adams HH, Jahanshad N, Chauhan G, Stein JL, Hofer E, et al. Novel genetic loci associated with hippocampal volume. Nat Commun. 2017;8:13624.\n\nAraghi M, Shipley MJ, Wilkinson IB, McEniery CM, Valencia-Hernandez CA, Kivimaki M, et al. Association of aortic stiffness with cognitive decline: Whitehall II longitudinal cohort study. Eur J Epidemiol. 2019. https://doi.org/10.1007/s10654-019-00586-3.\n\nBinder N, Balmford J, Schumacher M. A multi-state model based reanalysis of the Framingham Heart Study: is dementia incidence really declining? Eur J Epidemiol. 2019;34(11):1075–83.\n\nGhaderi S, Berg-Hansen P, Bakken IJ, Magnus P, Trogstad L, Haberg SE. Hospitalization following influenza infection and pandemic vaccination in multiple sclerosis patients: a nationwide population-based registry study from Norway. Eur J Epidemiol. 2020;35:355–362. https://doi.org/10.1007/s10654-019-00595-2.\n\nMurley C, Friberg E, Hillert J, Alexanderson K, Yang F. Validation of multiple sclerosis diagnoses in the Swedish National Patient Register. Eur J Epidemiol. 2019;34(12):1161–9.\n\nRichardson C, Stephan BCM, Robinson L, Brayne C, Matthews FE, Cognitive Function Ageing S. Two-decade change in prevalence of cognitive impairment in the UK. Eur J Epidemiol. 2019;34(11):1085–92.\n\nRist PM, Buring JE, Rexrode KM, Cook NR, Rost NS. Prospectively collected lifestyle and health information as risk factors for white matter hyperintensity volume in stroke patients. Eur J Epidemiol. 2019;34(10):957–65.\n\nSommerlad A, Perera G, Mueller C, Singh-Manoux A, Lewis G, Stewart R, et al. Hospitalisation of people with dementia: evidence from English electronic health records from 2008 to 2016. Eur J Epidemiol. 2019;34(6):567–77.\n\nWilkinson T, Schnier C, Bush K, Rannikmae K, Henshall DE, Lerpiniere C, et al. Identifying dementia outcomes in UK Biobank: a validation study of primary care, hospital admissions and mortality data. Eur J Epidemiol. 2019;34(6):557–65.\n\nGrasset L, Peres K, Joly P, Sabathe C, Foubert-Samier A, Dartigues JF, et al. Secular trends of mortality and dementia-free life expectancy over a 10-year period in France. Eur J Epidemiol. 2019;34(2):115–23.\n\nHayat SA, Luben R, Dalzell N, Moore S, Hogervorst E, Matthews FE, et al. Understanding the relationship between cognition and death: a within cohort examination of cognitive measures and mortality. Eur J Epidemiol. 2018;33(11):1049–62.\n\nKobayashi LC, Berkman LF, Wagner RG, Kahn K, Tollman S, Subramanian SV. Education modifies the relationship between height and cognitive function in a cross-sectional population-based study of older adults in Rural South Africa. Eur J Epidemiol. 2019;34(2):131–9.\n\nLi GW, Lip GYH, Holbrook A, Chang YP, Larsen TB, Sun X, et al. Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies. Eur J Epidemiol. 2019;34(2):173–90.\n\nNael V, Peres K, Dartigues JF, Letenneur L, Amieva H, Arleo A, et al. Vision loss and 12-year risk of dementia in older adults: the 3C cohort study. Eur J Epidemiol. 2019;34(2):141–52.\n\nOsler M, Christensen GT, Mortensen EL, Christensen K, Garde E, Rozing MP. Hearing loss, cognitive ability, and dementia in men age 19–78 years. Eur J Epidemiol. 2019;34(2):125–30.\n\nBokenberger K, Sjolander A, Aslan AKD, Karlsson IK, Akerstedt T, Pedersen NL. Shift work and risk of incident dementia: a study of two population-based cohorts. Eur J Epidemiol. 2018;33(10):977–87.\n\nDarweesh SKL, Wolters FJ, Ikram MA, Bos D, Hofman A. Broadening the scope of epidemiologic dementia research. Eur J Epidemiol. 2018;33(7):617–20.\n\nEvans S, McRae-McKee K, Wong MM, Hadjichrysanthou C, De Wolf F, Anderson R. The importance of endpoint selection: how effective does a drug need to be for success in a clinical trial of a possible Alzheimer's disease treatment? Eur J Epidemiol. 2018;33(7):635–44.\n\nGlymour MM, Brickman AM, Kivimaki M, Mayeda ER, Chene G, Dufouil C, et al. Will biomarker-based diagnosis of Alzheimer's disease maximize scientific progress? Evaluating proposed diagnostic criteria. Eur J Epidemiol. 2018;33(7):607–12.\n\nKuller LH. A new era for dementia epidemiology: Alzheimer's disease, hardening of arteries, or just old age? Eur J Epidemiol. 2018;33(7):613–6.\n\nMarin B, Fontana A, Arcuti S, Copetti M, Boumediene F, Couratier P, et al. Age-specific ALS incidence: a dose-response meta-analysis. Eur J Epidemiol. 2018;33(7):621–34.\n\nOwer AK, Hadjichrysanthou C, Gras L, Goudsmit J, Anderson RM, de Wolf F, et al. Temporal association patterns and dynamics of amyloid-beta and tau in Alzheimer's disease. Eur J Epidemiol. 2018;33(7):657–66.\n\nVangen-Lonne AM, Ueda P, Gulayin P, Wilsgaard T, Mathiesen EB, Danaei G. Hypothetical interventions to prevent stroke: an application of the parametric g-formula to a healthy middle-aged population. Eur J Epidemiol. 2018;33(6):557–66.\n\nVlaar T, Kab S, Schwaab Y, Frery N, Elbaz A, Moisan F. Association of Parkinson's disease with industry sectors: a French nationwide incidence study. Eur J Epidemiol. 2018;33(11):1101–11.\n\nWickstrom R, Skiold B, Petersson G, Stephansson O, Altman M. Moderate neonatal hypoglycemia and adverse neurological development at 2–6 years of age. Eur J Epidemiol. 2018;33(10):1011–20.\n\nXue BW, Cadar D, Fleischmann M, Stansfeld S, Carr E, Kivimaki M, et al. Effect of retirement on cognitive function: the Whitehall II cohort study. Eur J Epidemiol. 2018;33(10):989–1001.\n\nBhushan A, Fondell E, Ascherio A, Yuan CZ, Grodstein F, Willett W. Adherence to Mediterranean diet and subjective cognitive function in men. Eur J Epidemiol. 2018;33(2):223–34.\n\nLaursen ASD, Dahm CC, Johnsen SP, Tjonneland A, Overvad K, Jakobsen MU. Substitutions of dairy product intake and risk of stroke: a Danish cohort study. Eur J Epidemiol. 2018;33(2):201–12.\n\nThygesen SK, Olsen M, Pedersen L, Henderson VW, Ostergaard JR, Sorensen HT. Respiratory distress syndrome in preterm infants and risk of epilepsy in a Danish cohort. Eur J Epidemiol. 2018;33(3):313–21.\n\nFondell E, Townsend MK, Unger LD, Okereke OI, Grodstein F, Ascherio A, et al. Physical activity across adulthood and subjective cognitive function in older men. Eur J Epidemiol. 2018;33(1):79–877.\n\nColijn JM, Buitendijk GHS, Prokofyeva E, Alves D, Cachulo ML, Khawaja AP, et al. Prevalence of age-related macular degeneration in Europe: the past and the future. Ophthalmology. 2017;124(12):1753–63.\n\nColijn JM, den Hollander AI, Demirkan A, Cougnard-Gregoire A, Verzijden T, Kersten E, et al. Increased high-density lipoprotein levels associated with age-related macular degeneration: evidence from the EYE-RISK and European Eye Epidemiology Consortia. Ophthalmology. 2019;126(3):393–406.\n\nCorominas J, Colijn JM, Geerlings MJ, Pauper M, Bakker B, Amin N, et al. Whole-exome sequencing in age-related macular degeneration identifies rare variants in COL8A1, a component of Bruch's Membrane. Ophthalmology. 2018;125(9):1433–43.\n\nMerle BMJ, Colijn JM, Cougnard-Gregoire A, de Koning-Backus APM, Delyfer MN, Kiefte-de Jong JC, et al. Mediterranean diet and incidence of advanced age-related macular degeneration: the EYE-RISK Consortium. Ophthalmology. 2019;126(3):381–90.\n\nJoachim N, Kifley A, Colijn JM, Lee KE, Buitendijk GHS, Klein BEK, et al. Joint contribution of genetic susceptibility and modifiable factors to the progression of age-related macular degeneration over 10 years: the three continent AMD consortium report. Ophthalmol Retina. 2018;2(7):684–93.\n\nde Koning-Backus APM, Buitendijk GHS, Kiefte-de Jong JC, Colijn JM, Hofman A, Vingerling JR, et al. Intake of vegetables, fruit, and fish is beneficial for age-related macular degeneration. Am J Ophthalmol. 2019;198:70–9.\n\nTedja MS, Wojciechowski R, Hysi PG, Eriksson N, Furlotte NA, Verhoeven VJM, et al. Genome-wide association meta-analysis highlights light-induced signaling as a driver for refractive error. Nat Genet. 2018;50(6):834–48.\n\nTideman JW, Snabel MC, Tedja MS, van Rijn GA, Wong KT, Kuijpers RW, et al. Association of axial length with risk of uncorrectable visual impairment for Europeans with myopia. JAMA Ophthalmol. 2016;134(12):1355–63.\n\nAschard H, Kang JH, Iglesias AI, Hysi P, Cooke Bailey JN, Khawaja AP, et al. Genetic correlations between intraocular pressure, blood pressure and primary open-angle glaucoma: a multi-cohort analysis. Eur J Hum Genet. 2017;25(11):1261–7.\n\nIglesias AI, Ong JS, Khawaja AP, Gharahkhani P, Tedja MS, Verhoeven VJM, et al. Determining possible shared genetic architecture between myopia and primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2019;60(8):3142–9.\n\nGhanbari M, Iglesias AI, Springelkamp H, van Duijn CM, Ikram MA, Dehghan A, et al. A genome-wide scan for MicroRNA-related genetic variants associated with primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2017;58(12):5368–77.\n\nMauschitz MM, Bonnemaijer PWM, Diers K, Rauscher FG, Elze T, Engel C, et al. Systemic and ocular determinants of peripapillary retinal nerve fiber layer thickness measurements in the European Eye Epidemiology (E3) population. Ophthalmology. 2018;125(10):1526–36.\n\nMutlu U, Ikram MK, Roshchupkin GV, Bonnemaijer PWM, Colijn JM, Vingerling JR, et al. Thinner retinal layers are associated with changes in the visual pathway: a population-based study. Hum Brain Mapp. 2018;39(11):4290–301.\n\nWen KX, Mutlu U, Ikram MK, Kavousi M, Klaver CC, Tiemeier H, et al. The retinal microcirculation in migraine: the Rotterdam Study. Cephalalgia. 2018;38(4):736–43.\n\nLivingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. Lancet. 2017;390(10113):2673–734.\n\nDeal JA, Betz J, Yaffe K, Harris T, Purchase-Helzner E, Satterfield S, et al. Hearing impairment and incident dementia and cognitive decline in older adults: the health ABC Study. J Gerontol A Biol Sci Med Sci. 2017;72(5):703–9.\n\nSmits C, Kapteyn TS, Houtgast T. Development and validation of an automatic speech-in-noise screening test by telephone. Int J Audiol. 2004;43(1):15–28.\n\nCox RM, Alexander GC. The International Outcome Inventory for Hearing Aids (IOI-HA): psychometric properties of the English version. Int J Audiol. 2002;41(1):30–5.\n\nNewman CW, Sandridge SA, Bolek L. Development and psychometric adequacy of the screening version of the tinnitus handicap inventory. Otol Neurotol. 2008;29(3):276–81.\n\nHomans NC, Metselaar RM, Dingemanse JG, van der Schroeff MP, Brocaar MP, Wieringa MH, et al. Prevalence of age-related hearing loss, including sex differences, in older adults in a large cohort study. Laryngoscope. 2017;127(3):725–30.\n\nRigters SC, Metselaar M, Wieringa MH, Baatenburg de Jong RJ, Hofman A, Goedegebure A. Contributing determinants to hearing loss in elderly men and women: results from the population-based Rotterdam Study. Audiol Neurootol. 2016;21(Suppl 1):10–5.\n\nCroll PH, Voortman T, Vernooij MW, Baatenburg de Jong RJ, Lin FR, Rivadeneira F, et al. The association between obesity, diet quality and hearing loss in older adults. Aging (Albany NY). 2019;11(1):48–62.\n\nRigters SC, Bos D, Metselaar M, Roshchupkin GV, Baatenburg de Jong RJ, Ikram MA, et al. Hearing impairment is associated with smaller brain volume in aging. Front Aging Neurosci. 2017;9:2.\n\nRigters SC, Cremers LGM, Ikram MA, van der Schroeff MP, de Groot M, Roshchupkin GV, et al. White-matter microstructure and hearing acuity in older adults: a population-based cross-sectional DTI study. Neurobiol Aging. 2018;61:124–31.\n\nAmin N, de Vrij FMS, Baghdadi M, Brouwer RWW, van Rooij JGJ, Jovanova O, et al. A rare missense variant in RCL1 segregates with depression in extended families. Mol Psychiatry. 2018;23(5):1120–6.\n\nWray NR, Ripke S, Mattheisen M, Trzaskowski M, Byrne EM, Abdellaoui A, et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet. 2018;50(5):668–81.\n\nStory Jovanova O, Nedeljkovic I, Spieler D, Walker RM, Liu C, Luciano M, et al. DNA methylation signatures of depressive symptoms in middle-aged and elderly persons: meta-analysis of multiethnic epigenome-wide studies. JAMA Psychiatry. 2018;75(9):949–59.\n\nSaeed Mirza S, Ikram MA, Freak-Poli R, Hofman A, Rizopoulos D, Tiemeier H. 12 year trajectories of depressive symptoms in community-dwelling older adults and the subsequent risk of death over 13 years. J Gerontol A Biol Sci Med Sci. 2018;73(6):820–7.\n\nSchmitz N, Deschenes SS, Burns RJ, Danna SM, Franco OH, Ikram MA, et al. Cardiometabolic dysregulation and cognitive decline: potential role of depressive symptoms. Br J Psychiatry. 2018;212(2):96–102.\n\nKocevska D, Cremers LGM, Lysen TS, Luik AI, Ikram MA, Vernooij MW, et al. Sleep complaints and cerebral white matter: a prospective bidirectional study. J Psychiatr Res. 2019;112:77–82.\n\nKocevska D, Tiemeier H, Lysen TS, de Groot M, Muetzel RL, Van Someren EJW, et al. The prospective association of objectively measured sleep and cerebral white matter microstructure in middle-aged and older persons. Sleep. 2019. https://doi.org/10.1093/sleep/zsz140.\n\nLysen TS, Wolters FJ, Luik AI, Ikram MK, Tiemeier H, Ikram MA. Subjective sleep quality is not associated with incident dementia: the Rotterdam Study. J Alzheimers Dis. 2018;64(1):239–47.\n\nLysen TS, Darweesh SKL, Ikram MK, Luik AI, Ikram MA. Sleep and risk of parkinsonism and Parkinson's disease: a population-based study. Brain. 2019;142:2013–22.\n\nJones SE, van Hees VT, Mazzotti DR, Marques-Vidal P, Sabia S, van der Spek A, et al. Genetic studies of accelerometer-based sleep measures yield new insights into human sleep behaviour. Nat Commun. 2019;10(1):1585.\n\nDashti HS, Jones SE, Wood AR, Lane JM, van Hees VT, Wang H, et al. Genome-wide association study identifies genetic loci for self-reported habitual sleep duration supported by accelerometer-derived estimates. Nat Commun. 2019;10(1):1100.\n\nNeumann A, Direk N, Crawford AA, Mirza S, Adams H, Bolton J, et al. The low single nucleotide polymorphism heritability of plasma and saliva cortisol levels. Psychoneuroendocrinology. 2017;85:88–95.\n\nSaavedra Perez HC, Direk N, Milic J, Ikram MA, Hofman A, Tiemeier H. The impact of complicated grief on diurnal cortisol levels two years after loss: a population-based study. Psychosom Med. 2017;79(4):426–33.\n\nMilic J, Saavedra Perez H, Zuurbier LA, Boelen PA, Rietjens JA, Hofman A, et al. The longitudinal and cross-sectional associations of grief and complicated grief with sleep quality in older adults. Behav Sleep Med. 2019;17(1):31–40.\n\nPerez HCS, Ikram MA, Direk N, Tiemeier H. Prolonged grief and cognitive decline: a prospective population-based study in middle-aged and older persons. Am J Geriatr Psychiatry. 2018;26(4):451–60.\n\nChen RQ, Tedroff K, Villamor E, Lu DH, Cnattingius S. Risk of intellectual disability in children born appropriate-for-gestational-age at term or post-term: impact of birth weight for gestational age and gestational age. Eur J Epidemiol. 2020;35(3):273–82.\n\nLee BK, Gross R, Francis RW, Karlsson H, Schendel DE, Sourander A, et al. Birth seasonality and risk of autism spectrum disorder. Eur J Epidemiol. 2019;34(8):785–92.\n\nStrohmaier S, Devore EE, Vetter C, Eliassen AH, Rosner B, Okereke OI, et al. Night shift work before and during pregnancy in relation to depression and anxiety in adolescent and young adult offspring. Eur J Epidemiol. 2019;34(7):625–35.\n\nModabbernia A, Sandin S, Gross R, Leonard H, Gissler M, Parner ET, et al. Apgar score and risk of autism. Eur J Epidemiol. 2019;34(2):105–14.\n\nTiemeier H, McCormick MC. The Apgar paradox. Eur J Epidemiol. 2019;34(2):103–4.\n\nZhong QY, Mittal LP, Nathan MD, Brown KM, Gonzalez DK, Cai TR, et al. Use of natural language processing in electronic medical records to identify pregnant women with suicidal behavior: towards a solution to the complex classification problem. Eur J Epidemiol. 2019;34(2):153–62.\n\nHeuvelman H, Abel K, Wicks S, Gardner R, Johnstone E, Lee B, et al. Gestational age at birth and risk of intellectual disability without a common genetic cause. Eur J Epidemiol. 2018;33(7):667–78.\n\nMarotta PL, McCullagh CA. A cross-national analysis of the association between years of implementation of opioid substitution treatments and drug-related deaths in Europe from 1995 to 2013. Eur J Epidemiol. 2018;33(7):679–88.\n\nBranstrom R, Hatzenbuehler ML, Tinghog P, Pachankis JE. Sexual orientation differences in outpatient psychiatric treatment and antidepressant usage: evidence from a population-based study of siblings. Eur J Epidemiol. 2018;33(6):591–9.\n\nAgusti A, Faner R, Donaldson G, Heuvelin E, Breyer-Kohansal R, Melén E, et al. Chronic Airway Diseases Early Stratification (CADSET): a new ERS Clinical Research Collaboration. Eur Respir J. 2019;53(3):1900217.\n\nHancock DB, Eijgelsheim M, Wilk JB, Gharib SA, Loehr LR, Marciante KD, et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet. 2010;42(1):45–52.\n\nArtigas MS, Loth DW, Wain LV, Gharib SA, Obeidat M, Tang WB, et al. Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet. 2011;43(11):1082–U70.\n\nLoth DW, Artigas MS, Gharib SA, Wain LV, Franceschini N, Koch B, et al. Genome-wide association analysis identifies six new loci associated with forced vital capacity. Nat Genet. 2014;46(7):669–77.\n\nTerzikhan N, Sun F, Verhamme FM, Adams HHH, Loth D, Bracke KR, et al. Heritability and genome-wide association study of diffusing capacity of the lung. Eur Respir J. 2018;52(3):1800647.\n\nde Roos EW, Lahousse L, Verhamme KMC, Braunstahl G-J, Ikram MA, in ‘t Veen JCCM, et al. Asthma and its comorbidities in middle-aged and older adults; the Rotterdam Study. Respir Med. 2018;139:6–12.\n\nDemenais F, Margaritte-Jeannin P, Barnes KC, Cookson WOC, Altmüller J, Ang W, et al. Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks. Nat Genet. 2018;50(1):42–53.\n\nTerzikhan N, Lahousse L, Verhamme KMC, Franco OH, Ikram AM, Stricker BH, et al. COPD is associated with an increased risk of peripheral artery disease and mortality. ERJ Open Res. 2018;4(4):00086–2018.\n\nLahousse L, Niemeijer MN, van den Berg ME, Rijnbeek PR, Joos GF, Hofman A, et al. Chronic obstructive pulmonary disease and sudden cardiac death: the Rotterdam study. Eur Heart J. 2015;36(27):1754–61.\n\nGrymonprez M, Vakaet V, Kavousi M, Stricker BH, Ikram MA, Heeringa J, et al. Chronic obstructive pulmonary disease and the development of atrial fibrillation. Int J Cardiol. 2019;276:118–24.\n\nHobbs BD, de Jong K, Lamontagne M, Bosse Y, Shrine N, Artigas MS, et al. Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis. Nat Genet. 2017;49(3):426–32.\n\nNedeljkovic I, Carnero-Montoro E, Lahousse L, van der Plaat DA, de Jong K, Vonk JM, et al. Understanding the role of the chromosome 15q25.1 in COPD through epigenetics and transcriptomics. Eur J Hum Genet. 2018;26(5):709–22.\n\nNedeljkovic I, Lahousse L, Carnero-Montoro E, Faiz A, Vonk JM, de Jong K, et al. COPD GWAS variant at 19q13.2 in relation with DNA methylation and gene expression. Hum Mol Genet. 2017;27(2):396–405.\n\nMoreira EM, Gall H, Leening MJG, Lahousse L, Loth DW, Krijthe BP, et al. Prevalence of pulmonary hypertension in the general population: the Rotterdam Study. PLoS ONE. 2015;10(6):e0130072.\n\nCepelis A, Brumpton BM, Laugsand LE, Dalen H, Langhammer A, Janszky I, et al. Asthma, asthma control and risk of acute myocardial infarction: HUNT study. Eur J Epidemiol. 2019;34(10):967–77.\n\nTimm S, Frydenberg M, Abramson MJ, Bertelsen RJ, Braback L, Benediktsdottir B, et al. Asthma and selective migration from farming environments in a three-generation cohort study. Eur J Epidemiol. 2019;34(6):601–9.\n\nWeinmayr G, Jaensch A, Ruelius AK, Forastiere F, Strachan DP, Weiland SK, et al. Can environment or allergy explain international variation in prevalence of wheeze in childhood? Eur J Epidemiol. 2019;34(5):509–20.\n\nCampos-Obando N, Lahousse L, Brusselle G, Stricker BH, Hofman A, Franco OH, et al. Serum phosphate levels are related to all-cause, cardiovascular and COPD mortality in men. Eur J Epidemiol. 2018;33(9):859–71.\n\nKim Y, White T, Wijndaele K, Westgate K, Sharp SJ, Helge JW, et al. The combination of cardiorespiratory fitness and muscle strength, and mortality risk. Eur J Epidemiol. 2018;33(10):953–64.\n\nFaerk G, Colak Y, Afzal S, Nordestgaard BG. Low concentrations of 25-hydroxyvitamin D and long-term prognosis of COPD: a prospective cohort study. Eur J Epidemiol. 2018;33(6):567–77.\n\nMattila T, Vasankari T, Rissanen H, Knekt P, Puukka P, Heliovaara M. Airway obstruction and the risk of myocardial infarction and death from coronary heart disease: a national health examination survey with a 33-year follow-up period. Eur J Epidemiol. 2018;33(1):89–988.\n\nvan Rooij JGJ, Jhamai M, Arp PP, Nouwens SCA, Verkerk M, Hofman A, et al. Population-specific genetic variation in large sequencing data sets: why more data is still better. Eur J Hum Genet. 2017;25(10):1173–5.\n\nBoomsma DI, Wijmenga C, Slagboom EP, Swertz MA, Karssen LC, Abdellaoui A, et al. The genome of the Netherlands: design, and project goals. Eur J Hum Genet. 2014;22(2):221–7.\n\nEvans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem. 2009;81(16):6656–67.\n\nMinikel EV, Vallabh SM, Lek M, Estrada K, Samocha KE, Sathirapongsasuti JF, et al. Quantifying prion disease penetrance using large population control cohorts. Sci Transl Med. 2016;8(322):322ra9.\n\nvan den Akker EB, Pitts SJ, Deelen J, Moed MH, Potluri S, van Rooij J, et al. Uncompromised 10-year survival of oldest old carrying somatic mutations in DNMT3A and TET2. Blood. 2016;127(11):1512–5.\n\nMaas SCE, Vidaki A, Wilson R, Teumer A, Liu F, van Meurs JBJ, et al. Validated inference of smoking habits from blood with a finite DNA methylation marker set. Eur J Epidemiol. 2019;34(11):1055–74\n\nLiu C, Marioni RE, Hedman AK, Pfeiffer L, Tsai PC, Reynolds LM, et al. A DNA methylation biomarker of alcohol consumption. Mol Psychiatry. 2018;23(2):422–33.\n\nLigthart S, Marzi C, Aslibekyan S, Mendelson MM, Conneely KN, Tanaka T, et al. DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases. Genome Biol. 2016;17(1):255.\n\nBraun KVE, Dhana K, de Vries PS, Voortman T, van Meurs JBJ, Uitterlinden AG, et al. Epigenome-wide association study (EWAS) on lipids: the Rotterdam Study. Clin Epigenetics. 2017;9:15.\n\nWahl S, Drong A, Lehne B, Loh M, Scott WR, Kunze S, et al. Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity. Nature. 2017;541(7635):81–6.\n\nMa J, Nano J, Ding J, Zheng Y, Hennein R, Liu C, et al. A peripheral blood DNA methylation signature of hepatic fat reveals a potential causal pathway for nonalcoholic fatty liver disease. Diabetes. 2019;68(5):1073–83.\n\nNano J, Ghanbari M, Wang W, de Vries PS, Dhana K, Muka T, et al. Epigenome-wide association study identifies methylation sites associated with liver enzymes and hepatic steatosis. Gastroenterology. 2017;153(4):1096–106e2.\n\nGhanbari M, Peters MJ, de Vries PS, Boer CG, van Rooij JGJ, Lee YC, et al. A systematic analysis highlights multiple long non-coding RNAs associated with cardiometabolic disorders. J Hum Genet. 2018;63(4):431–46.\n\nGhanbari M, Munshi ST, Ma B, Lendemeijer B, Bansal S, Adams HH, et al. A functional variant in the miR-142 promoter modulating its expression and conferring risk of Alzheimer disease. Hum Mutat. 2019;40(11):2131–2145.\n\nAhmad S, Bannister C, van der Lee SJ, Vojinovic D, Adams HHH, Ramirez A, et al. Disentangling the biological pathways involved in early features of Alzheimer's disease in the Rotterdam Study. Alzheimers Dement. 2018;14(7):848–57.\n\nBjork J, Andersson T, Ahlbom A. Commonly used estimates of the genetic contribution to disease are subject to the same fallacies as bad luck estimates. Eur J Epidemiol. 2019;34(11):987–92.\n\nHunter DJ. Adventures in the environment and genes. Eur J Epidemiol. 2019;34(12):1111–7.\n\nMaas SCE, Vidaki A, Wilson R, Teumer A, Liu F, van Meurs JBJ, et al. Validated inference of smoking habits from blood with a finite DNA methylation marker set. Eur J Epidemiol. 2019;34(11):1055–74.\n\nMukamal KJ, Stampfer MJ, Rimm EB. Genetic instrumental variable analysis: time to call Mendelian randomization what it is. The example of alcohol and cardiovascular disease. Eur J Epidemiol. 2020;35(2):93–7.\n\nEnthoven CA, LodewijkTideman JW, Polling JR, Tedja MS, Raat H, Iglesias AI, et al. Interaction between lifestyle and genetic susceptibility in myopia: the Generation R study. Eur J Epidemiol. 2019;34(8):777–84.\n\nGao X, Gao X, Zhang Y, Holleczek B, Schottker B, Brenner H. Oxidative stress and epigenetic mortality risk score: associations with all-cause mortality among elderly people. Eur J Epidemiol. 2019;34(5):451–62.\n\nPerduca V, Alexandrov LB, Kelly-Irving M, Delpierre C, Omichessan H, Little MP, et al. Stem cell replication, somatic mutations and role of randomness in the development of cancer. Eur J Epidemiol. 2019;34(5):439–45.\n\nRasmussen IJ, Tybjaerg-Hansen A, Rasmussen KL, Nordestgaard BG, Frikke-Schmidt R. Blood-brain barrier transcytosis genes, risk of dementia and stroke: a prospective cohort study of 74,754 individuals. Eur J Epidemiol. 2019;34(6):579–90.\n\nMai XM, Videm V, Sheehan NA, Chen Y, Langhammer A, Sun YQ. Potential causal associations of serum 25-hydroxyvitamin D with lipids: a Mendelian randomization approach of the HUNT study. Eur J Epidemiol. 2019;34(1):57–66.\n\nBurgess S, Labrecque JA. Mendelian randomization with a binary exposure variable: interpretation and presentation of causal estimates. Eur J Epidemiol. 2018;33(10):947–52.\n\nCastagne R, Gares V, Karimi M, Chadeau-Hyam M, Vineis P, Delpierre C, et al. Allostatic load and subsequent all-cause mortality: which biological markers drive the relationship? Findings from a UK birth cohort. Eur J Epidemiol. 2018;33(5):441–58.\n\nHang D, Nan HM, Kvaerner AS, De Vivo I, Chan AT, Hu ZB, et al. Longitudinal associations of lifetime adiposity with leukocyte telomere length and mitochondrial DNA copy number. Eur J Epidemiol. 2018;33(5):485–95.\n\nLiu L, Nevo D, Nishihara R, Cao Y, Song MY, Twombly TS, et al. Utility of inverse probability weighting in molecular pathological epidemiology. Eur J Epidemiol. 2018;33(4):381–92.\n\nWilson MM, Thomas DR, Rubenstein LZ, Chibnall JT, Anderson S, Baxi A, et al. Appetite assessment: simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr. 2005;82(5):1074–81.\n\nKoolhaas CM, van Rooij FJ, Cepeda M, Tiemeier H, Franco OH, Schoufour JD. Physical activity derived from questionnaires and wrist-worn accelerometers: comparability and the role of demographic, lifestyle, and health factors among a population-based sample of older adults. Clin Epidemiol. 2018;10:1–16.\n\nCraig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95.\n\nEeftens M, Beelen R, de Hoogh K, Bellander T, Cesaroni G, Cirach M, et al. Development of land use regression models for PM(25), PM(2.5) absorbance, PM(1.0) and PM(coarse) in 20 European study areas; results of the ESCAPE project. Environ Sci Technol. 2012;46(20):11195–205.\n\nKoolhaas CM, van Rooij FJA, Schoufour JD, Cepeda M, Tiemeier H, Brage S, et al. Objective measures of activity in the elderly: distribution and associations with demographic and health factors. J Am Med Dir Assoc. 2017;18(10):838–47.\n\nBrinkman S, Voortman T, Kiefte-de Jong JC, van Rooij FJA, Ikram MA, Rivadeneira F, et al. The association between lifestyle and overall health, using the frailty index. Arch Gerontol Geriatr. 2018;76:85–91.\n\nKoolhaas CM, Dhana K, Schoufour JD, Lahousse L, van Rooij FJA, Ikram MA, et al. Physical activity and cause-specific mortality: the Rotterdam Study. Int J Epidemiol. 2018;47(5):1705–13.\n\nWood AM, Kaptoge S, Butterworth AS, Willeit P, Warnakula S, Bolton T, et al. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet. 2018;391(10129):1513–23.\n\nKoolhaas CM, Dhana K, Schoufour JD, Ikram MA, Kavousi M, Franco OH. Impact of physical activity on the association of overweight and obesity with cardiovascular disease: the Rotterdam Study. Eur J Prev Cardiol. 2017;24(9):934–41.\n\nKoolhaas CM, Dhana K, van Rooij FJA, Schoufour JD, Hofman A, Franco OH. Physical activity types and health-related quality of life among middle-aged and elderly adults: the Rotterdam Study. The journal of nutrition, health & aging. 2018;22(2):246–53.\n\nAlferink LJ, Kiefte-de Jong JC, Erler NS, Veldt BJ, Schoufour JD, de Knegt RJ, et al. Association of dietary macronutrient composition and non-alcoholic fatty liver disease in an ageing population: the Rotterdam Study. Gut. 2019;68(6):1088–98.\n\nde Jonge EAL, Rivadeneira F, Erler NS, Hofman A, Uitterlinden AG, Franco OH, et al. Dietary patterns in an elderly population and their relation with bone mineral density: the Rotterdam Study. Eur J Nutr. 2018;57(1):61–73.\n\nCroll PH, Voortman T, Ikram MA, Franco OH, Schoufour JD, Bos D, et al. Better diet quality relates to larger brain tissue volumes: the Rotterdam Study. Neurology. 2018;90(24):e2166–e73.\n\nde Haas SCM, de Jonge EAL, Voortman T, Graaff JS, Franco OH, Ikram MA, et al. Dietary patterns and changes in frailty status: the Rotterdam study. Eur J Nutr. 2018;57(7):2365–75.\n\nSchoufour JD, Erler NS, Jaspers L, Kiefte-de Jong JC, Voortman T, Ziere G, et al. Design of a frailty index among community living middle-aged and older people: the Rotterdam study. Maturitas. 2017;97:14–20.\n\nChen Z, Franco OH, Lamballais S, Ikram MA, Schoufour JD, Muka T, et al. Associations of specific dietary protein with longitudinal insulin resistance, prediabetes and type 2 diabetes: the Rotterdam Study. Clin Nutr. 2020;39(1):242–9.\n\nChen Z, Schoufour JD, Rivadeneira F, Lamballais S, Ikram MA, Franco OH, et al. Plant-based diet and adiposity over time in a middle-aged and elderly population: the Rotterdam Study. Epidemiology (Cambridge, Mass). 2019;30(2):303–10.\n\nStringa N, Brahimaj A, Zaciragic A, Dehghan A, Ikram MA, Hofman A, et al. Relation of antioxidant capacity of diet and markers of oxidative status with C-reactive protein and adipocytokines: a prospective study. Metab Clin Exp. 2017;71:171–81.\n\nFiorito G, McCrory C, Robinson O, Carmeli C, Rosales CO, Zhang Y, et al. Socioeconomic position, lifestyle habits and biomarkers of epigenetic aging: a multi-cohort analysis. Aging (Albany NY). 2019;11(7):2045–70.\n\nBraun KVE, Dhana K, de Vries PS, Voortman T, van Meurs JBJ, Uitterlinden AG, et al. Epigenome-wide association study (EWAS) on lipids: the Rotterdam Study. Clin Epigenet. 2017;9:15.\n\nDhana K, Braun KVE, Nano J, Voortman T, Demerath EW, Guan W, et al. An epigenome-wide association study of obesity-related traits. Am J Epidemiol. 2018;187(8):1662–9.\n\nKilpelainen TO, Bentley AR, Noordam R, Sung YJ, Schwander K, Winkler TW, et al. Multi-ancestry study of blood lipid levels identifies four loci interacting with physical activity. Nat Commun. 2019;10(1):376.\n\nSchoufour JD, de Jonge EAL, Kiefte-de Jong JC, van Lenthe FJ, Hofman A, Nunn SPT, et al. Socio-economic indicators and diet quality in an older population. Maturitas. 2018;107:71–7.\n\nvan der Toorn JE, Cepeda M, Kiefte-de Jong JC, Franco OH, Voortman T, Schoufour JD. Seasonal variation of diet quality in a large middle-aged and elderly Dutch population-based cohort. Eur J Nutr. 2020;59(2):493–504.\n\nCepeda M, Koolhaas CM, van Rooij FJA, Tiemeier H, Guxens M, Franco OH, et al. Seasonality of physical activity, sedentary behavior, and sleep in a middle-aged and elderly population: the Rotterdam study. Maturitas. 2018;110:41–50.\n\nCepeda M, Muka T, Ikram MA, Franco OH, Schoufour JD. Seasonality of insulin resistance, glucose, and insulin among middle-aged and elderly population: the Rotterdam Study. J Clin Endocrinol Metab. 2018;103(3):946–55.\n\nMerino J, Dashti HS, Li SX, Sarnowski C, Justice AE, Graff M, et al. Genome-wide meta-analysis of macronutrient intake of 91,114 European ancestry participants from the cohorts for heart and aging research in genomic epidemiology consortium. Mol Psychiatry. 2019;24(12):1920–32.\n\nNettleton JA, Follis JL, Ngwa JS, Smith CE, Ahmad S, Tanaka T, et al. Gene x dietary pattern interactions in obesity: analysis of up to 68 317 adults of European ancestry. Hum Mol Genet. 2015;24(16):4728–38.\n\nDing M, Huang T, Bergholdt HK, Nordestgaard BG, Ellervik C, Qi L. Dairy consumption, systolic blood pressure, and risk of hypertension: Mendelian randomization study. BMJ. 2017;356:j1000.\n\nDashti HS, Zuurbier LA, de Jonge E, Voortman T, Jacques PF, Lamon-Fava S, et al. Actigraphic sleep fragmentation, efficiency and duration associate with dietary intake in the Rotterdam Study. J Sleep Res. 2016;25(4):404–11.\n\nAbe SK, Saito E, Sawada N, Tsugane S, Ito H, Lin YS, et al. Green tea consumption and mortality in Japanese men and women: a pooled analysis of eight population-based cohort studies in Japan. Eur J Epidemiol. 2019;34(10):917–26.\n\nMackenbach JP, Valverde JR, Bopp M, Bronnum-Hansen H, Costa G, Deboosere P, et al. Progress against inequalities in mortality: register-based study of 15 European countries between 1990 and 2015. Eur J Epidemiol. 2019;34(12):1131–42.\n\nChen GC, Neelakantan N, Martin-Calvo N, Koh WP, Yuan JM, Bonaccio M, et al. Adherence to the Mediterranean diet and risk of stroke and stroke subtypes. Eur J Epidemiol. 2019;34(4):337–49.\n\nGignac F, Romaguera D, Fernandez-Barres S, Phillipat C, Esteban RG, Lopez-Vicente M, et al. Maternal nut intake in pregnancy and child neuropsychological development up to 8years old: a population-based cohort study in Spain. Eur J Epidemiol. 2019;34(7):661–73.\n\nGiovannucci E. Nutritional epidemiology: forest, trees and leaves. Eur J Epidemiol. 2019;34(4):319–25.\n\nHashemian M, Farvid MS, Poustchi H, Murphy G, Etemadi A, Hekmatdoost A, et al. The application of six dietary scores to a Middle Eastern population: a comparative analysis of mortality in a prospective study. Eur J Epidemiol. 2019;34(4):371–82.\n\nIoannidis JPA. Unreformed nutritional epidemiology: a lamp post in the dark forest. Eur J Epidemiol. 2019;34(4):327–31.\n\nKim Y, Je Y, Giovannucci E. Coffee consumption and all-cause and cause-specific mortality: a meta-analysis by potential modifiers. Eur J Epidemiol. 2019;34(8):731–52.\n\nLi XY, Yu CQ, Guo Y, Bian Z, Shen ZW, Yang L, et al. Association between tea consumption and risk of cancer: a prospective cohort study of 0.5 million Chinese adults. Eur J Epidemiol. 2019;34(8):753–63.\n\nSchwingshackl L, Knuppel S, Michels N, Schwedhelm C, Hoffmann G, Igbal K, et al. Intake of 12 food groups and disability-adjusted life years from coronary heart disease, stroke, type 2 diabetes, and colorectal cancer in 16 European countries. Eur J Epidemiol. 2019;34(8):765–75.\n\nTemple NJ, Conklin A. Prevalence of overweight and obesity in Western countries: discrepancies in published estimates. Eur J Epidemiol. 2019;34(7):711–3.\n\nvan den Brandt PA. Red meat, processed meat, and other dietary protein sources and risk of overall and cause-specific mortality in The Netherlands Cohort Study. Eur J Epidemiol. 2019;34(4):351–69.\n\nVerhoog S, Marques-Vidal P, Franco OH. Nutritional epidemiology, extinction or evolution? It is all about balance and moderation. Eur J Epidemiol. 2019;34(4):333–5.\n\nDale MTG, Magnus P, Leirgul E, Holmstrom H, Gjessing HK, Brodwall K, et al. Intake of sucrose-sweetened soft beverages during pregnancy and risk of congenital heart defects (CHD) in offspring: a Norwegian pregnancy cohort study. Eur J Epidemiol. 2019;34(4):383–96.\n\nJorgensen MB, Pedersen J, Thygesen LC, Lau CJ, Christensen AI, Becker U, et al. Alcohol consumption and labour market participation: a prospective cohort study of transitions between work, unemployment, sickness absence, and social benefits. Eur J Epidemiol. 2019;34(4):397–407.\n\nAntero-Jacquemin J, Pohar-Perme M, Rey G, Toussaint JF, Latouche A. The heart of the matter: years-saved from cardiovascular and cancer deaths in an elite athlete cohort with over a century of follow-up. Eur J Epidemiol. 2018;33(6):531–43.\n\nColpani V, Baena CP, Jaspers L, van Dijk GM, Farajzadegan Z, Dhana K, et al. Lifestyle factors, cardiovascular disease and all-cause mortality in middle-aged and elderly women: a systematic review and meta-analysis. Eur J Epidemiol. 2018;33(9):831–45.\n\nGalbete C, Schwingshackl L, Schwedhelm C, Boeing H, Schulze MB. Evaluating Mediterranean diet and risk of chronic disease in cohort studies: an umbrella review of meta-analyses. Eur J Epidemiol. 2018;33(10):909–31.\n\nKim R, Kawachi I, Coull BA, Subramanian SV. Patterning of individual heterogeneity in body mass index: evidence from 57 low- and middle-income countries. Eur J Epidemiol. 2018;33(8):741–50.\n\nPatterson R, McNamara E, Tainio M, de Sa TH, Smith AD, Sharp SJ, et al. Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta-analysis. Eur J Epidemiol. 2018;33(9):811–29.\n\nZhu DS, Chung HF, Pandeya N, Dobson AJ, Kuh D, Crawford SL, et al. Body mass index and age at natural menopause: an international pooled analysis of 11 prospective studies. Eur J Epidemiol. 2018;33(8):699–710.\n\nBergholdt HKM, Nordestgaard BG, Varbo A, Ellervik C. Lactase persistence, milk intake, and mortality in the Danish general population: a Mendelian randomization study. Eur J Epidemiol. 2018;33(2):171–81.\n\nFretts AM, Mete M, Howard BV, Best LG, Siscovick DS, Eilat-Adar S, et al. Physical activity and telomere length in American Indians: the Strong Heart Study. Eur J Epidemiol. 2018;33(5):497–500.\n\nHedstrom AK, Stawiarz L, Klareskog L, Alfredsson L. Smoking and susceptibility to rheumatoid arthritis in a Swedish population-based case-control study. Eur J Epidemiol. 2018;33(4):415–23.\n\nLukic M, Nilsson LM, Skeie G, Lindahl B, Braaten T. Coffee consumption and risk of rare cancers in Scandinavian countries. Eur J Epidemiol. 2018;33(3):287–302.\n\nMulligan AA, Lentjes MAH, Luben RN, Wareham NJ, Khaw KT. Weight change and 15 year mortality: results from the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) cohort study. Eur J Epidemiol. 2018;33(1):37–533.\n\nSong MY, Giovannucci E. Substitution analysis in nutritional epidemiology: proceed with caution. Eur J Epidemiol. 2018;33(2):137–40.\n\nTreur JL, Rozema AD, Mathijssen JJP, van Oers H, Vink JM. E-cigarette and waterpipe use in two adolescent cohorts: cross-sectional and longitudinal associations with conventional cigarette smoking. Eur J Epidemiol. 2018;33(3):323–34.\n\nvan den Brandt PA. Coffee or Tea? A prospective cohort study on the associations of coffee and tea intake with overall and cause-specific mortality in men versus women. Eur J Epidemiol. 2018;33(2):183–200.\n\nWillett WC. Diet and health-finding a path to Veritas. Eur J Epidemiol. 2018;33(2):127–35.\n\nFloyd JS, Bloch KM, Brody JA, Maroteau C, Siddiqui MK, Gregory R, et al. Pharmacogenomics of statin-related myopathy: meta-analysis of rare variants from whole-exome sequencing. PLoS ONE. 2019;14(6):e0218115.\n\nPostmus I, Warren HR, Trompet S, Arsenault BJ, Avery CL, Bis JC, et al. Meta-analysis of genome-wide association studies of HDL cholesterol response to statins. J Med Genet. 2016;53(12):835–45.\n\nAhmadizar F, Ochoa-Rosales C, Glisic M, Franco OH, Muka T, Stricker BH. Associations of statin use with glycaemic traits and incident type 2 diabetes. Br J Clin Pharmacol. 2019;85(5):993–1002.\n\nPavlovic J, Greenland P, Deckers JW, Brugts JJ, Kavousi M, Dhana K, et al. Comparison of ACC/AHA and ESC guideline recommendations following trial evidence for statin use in primary prevention of cardiovascular disease: results from the population-based Rotterdam Study. JAMA Cardiol. 2016;1(6):708–13.\n\nIrvin MR, Sitlani CM, Noordam R, Avery CL, Bis JC, Floyd JS, et al. Genome-wide meta-analysis of SNP-by9-ACEI/ARB and SNP-by-thiazide diuretic and effect on serum potassium in cohorts of European and African ancestry. Pharmacogenomics J. 2019;19(1):97–108.\n\nMahmoudpour SH, Veluchamy A, Siddiqui MK, Asselbergs FW, Souverein PC, de Keyser CE, et al. Meta-analysis of genome-wide association studies on the intolerance of angiotensin-converting enzyme inhibitors. Pharmacogenet Genomics. 2017;27(3):112–9.\n\nSeyerle AA, Sitlani CM, Noordam R, Gogarten SM, Li J, Li X, et al. Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiology. Pharmacogenomics J. 2018;18(2):215–26.\n\nKieboom BCT, Zietse R, Ikram MA, Hoorn EJ, Stricker BH. Thiazide but not loop diuretics is associated with hypomagnesaemia in the general population. Pharmacoepidemiol Drug Saf. 2018;27(11):1166–73.\n\nHam AC, van Dijk SC, Swart KMA, Enneman AW, van der Zwaluw NL, Brouwer-Brolsma EM, et al. Beta-blocker use and fall risk in older individuals: original results from two studies with meta-analysis. Br J Clin Pharmacol. 2017;83(10):2292–302.\n\nHam AC, Ziere G, Broer L, Swart KM, Enneman AW, van Dijk SC, et al. CYP2C9 genotypes modify benzodiazepine-related fall risk: original results from three studies with meta-analysis. J Am Med Dir Assoc. 2017;18(1):88e1–88e15.\n\nDujic T, Zhou K, Yee SW, van Leeuwen N, de Keyser CE, Javorsky M, et al. Variants in pharmacokinetic transporters and glycemic response to metformin: a metgen meta-analysis. Clin Pharmacol Ther. 2017;101(6):763–72.\n\nZhou K, Yee SW, Seiser EL, van Leeuwen N, Tavendale R, Bennett AJ, et al. Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin. Nat Genet. 2016;48(9):1055–9.\n\nFloyd JS, Sitlani CM, Avery CL, Noordam R, Li X, Smith AV, et al. Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group. Pharmacogenomics J. 2018;18(1):127–35.\n\nAarts N, Noordam R, Hofman A, Tiemeier H, Stricker BH, Visser LE. Self-reported indications for antidepressant use in a population-based cohort of middle-aged and elderly. Int J Clin Pharm. 2016;38(5):1311–7.\n\nAarts N, Zuurbier LA, Noordam R, Hofman A, Tiemeier H, Stricker BH, et al. Use of selective serotonin reuptake inhibitors and sleep quality: a population-based study. J Clin Sleep Med. 2016;12(7):989–95.\n\nHam AC, Aarts N, Noordam R, Rivadeneira F, Ziere G, Zillikens MC, et al. Use of selective serotonin reuptake inhibitors and bone mineral density change: a population-based longitudinal study in middle-aged and elderly individuals. J Clin Psychopharmacol. 2017;37(5):524–30.\n\nNoordam R, Aarts N, Peeters RP, Hofman A, Stricker BH, Visser LE. Selective serotonin reuptake inhibitors decrease pancreatic insulin secretion in older adults and increase the risk of insulin dependence in type 2 diabetes patients. J Clin Psychiatry. 2016;77(9):e1124–e9.\n\nNoordam R, Avery CL, Visser LE, Stricker BH. Identifying genetic loci affecting antidepressant drug response in depression using drug-gene interaction models. Pharmacogenomics. 2016;17(9):1029–40.\n\nNoordam R, Sitlani CM, Avery CL, Stewart JD, Gogarten SM, Wiggins KL, et al. A genome-wide interaction analysis of tricyclic/tetracyclic antidepressants and RR and QT intervals: a pharmacogenomics study from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium. J Med Genet. 2017;54(5):313–23.\n\nNoordam R, van den Berg ME, Niemeijer MN, Aarts N, Hofman A, Tiemeier H, et al. Antidepressants and heart-rate variability in older adults: a population-based study. Psychol Med. 2016;46(6):1239–47.\n\nAkoudad S, Aarts N, Noordam R, Ikram MA, Tiemeier H, Hofman A, et al. Antidepressant use is associated with an increased risk of developing microbleeds. Stroke. 2016;47(1):251–4.\n\nMulder M, Kiefte-de Jong JC, Goessens WH, de Visser H, Hofman A, Stricker BH, et al. Risk factors for resistance to ciprofloxacin in community-acquired urinary tract infections due to Escherichia coli in an elderly population. J Antimicrob Chemother. 2017;72(1):281–9.\n\nMulder M, Kiefte-de Jong JC, Goessens WHF, de Visser H, Ikram MA, Verbon A, et al. Diet as a risk factor for antimicrobial resistance in community-acquired urinary tract infections in a middle-aged and elderly population: a case-control study. Clin Microbiol Infect. 2019;25(5):613–9.\n\nMulder M, Radjabzadeh D, Hassing RJ, Heeringa J, Uitterlinden AG, Kraaij R, et al. The effect of antimicrobial drug use on the composition of the genitourinary microbiota in an elderly population. BMC Microbiol. 2019;19(1):9.\n\nStricker BH. Repeated interviews are much better for drug exposure assessment than a single baseline interview. Eur J Epidemiol. 2019;34(11):993–5.\n\nYang F, Yuan W, Liang H, Song XX, Yu YF, Gelaye B, et al. Preconceptional paternal antiepileptic drugs use and risk of congenital anomalies in offspring: a nationwide cohort study. Eur J Epidemiol. 2019;34(7):651–60.\n\nHallas J, Wang SV, Gagne JJ, Schneeweiss S, Pratt N, Pottegard A. Hypothesis-free screening of large administrative databases for unsuspected drug-outcome associations. Eur J Epidemiol. 2018;33(6):545–55.\n\nStricker BH. Adverse reaction signal detection methodology in pharmacoepidemiology. Eur J Epidemiol. 2018;33(6):507–8.\n\nRichardson DB, Keil AP. Challenges to studying population effects of medical treatments. Eur J Epidemiol. 2018;33(4):365–8.\n\nVinke EJ, Huizinga W, Bergtholdt M, Adams HH, Steketee RME, Papma JM, et al. Normative brain volumetry derived from different reference populations: impact on single-subject diagnostic assessment in dementia. Neurobiol Aging. 2019;84:9–16.\n\nZonneveld HI, Pruim RH, Bos D, Vrooman HA, Muetzel RL, Hofman A, et al. Patterns of functional connectivity in an aging population: the Rotterdam Study. Neuroimage. 2019;189:432–44.\n\nHuizinga W, Poot DHJ, Vernooij MW, Roshchupkin GV, Bron EE, Ikram MA, et al. A spatio-temporal reference model of the aging brain. Neuroimage. 2018;169:11–22.\n\nde Groot M, Cremers LG, Ikram MA, Hofman A, Krestin GP, van der Lugt A, et al. White matter degeneration with aging: longitudinal diffusion MR imaging analysis. Radiology. 2016;279(2):532–41.\n\nCremers LG, de Groot M, Hofman A, Krestin GP, van der Lugt A, Niessen WJ, et al. Altered tract-specific white matter microstructure is related to poorer cognitive performance: the Rotterdam Study. Neurobiol Aging. 2016;39:108–17.\n\nEvans TE, O'Sullivan MJ, de Groot M, Niessen WJ, Hofman A, Krestin GP, et al. White matter microstructure improves stroke risk prediction in the general population. Stroke. 2016;47(11):2756–62.\n\nSedaghat S, Cremers LG, de Groot M, Hofman A, van der Lugt A, Niessen WJ, et al. Lower microstructural integrity of brain white matter is related to higher mortality. Neurology. 2016;87(9):927–34.\n\nAkoudad S, Portegies ML, Koudstaal PJ, Hofman A, van der Lugt A, Ikram MA, et al. Cerebral microbleeds are associated with an increased risk of stroke: the Rotterdam Study. Circulation. 2015;132(6):509–16.\n\nAkoudad S, Wolters FJ, Viswanathan A, de Bruijn RF, van der Lugt A, Hofman A, et al. Association of cerebral microbleeds with cognitive decline and dementia. JAMA Neurol. 2016;73(8):934–43.\n\nBos D, Portegies ML, van der Lugt A, Bos MJ, Koudstaal PJ, Hofman A, et al"
    }
}